163318	1975	evaluation dye exclusion colony inhibition technique detection polyoma specific cell mediate immunity cellular immunity direct polyoma virus induced antigen observe c3h hej splenic lymphoid cell ncbitaxon10090 sensitize short term immunization schedule syngeneic polyoma 4198 4198v meshd009369 cell polyoma specificity response show presentation splenic cell dba 2j animal meshd014412 cytotoxic c3h 4198 4198v cell cell another cell line c3h origin polyoma specific response syngeneic system detectable dye exclusion assay colony inhibition procedure colony inhibition cell observe sensitize lymphoid cell allogeneic syngeneic system
163319	1975	potentiation ncbitaxon10515 associate virus ncbitaxon10310 transform cell ncbitaxon10310 ncbitaxon10310 transform cell line 333 8 9 inoculate adeno virus associate virus type 3 aav 3 examine immunofluorescent fa technique evidence aav 3 antigen synthesis antiserum make three meshd012967 dissociate structural polypeptide vp 1 vp 2 vp 3 aav 3 unit aav 3 virion use examine search aav 3 fa stainable antigen synthesize cell 333 8 9 cell inoculate aav 3 alone produce fa stainable antigen detect vp 1 vp 3 unit virion antiserum vp 2 antiserum coinfection aav 3 inoculate 333 8 9 cell with either ncbitaxon10515 ncbitaxon10515 ncbitaxon10298 ncbitaxon10298 helper permit formation fa stainable antigen detect antiserum include vp 2 antiserum contrast 333 8 9 cell bhk 21 cell fail produce aav 3 fa stainable antigen inoculate aav 3 alone addition either ncbitaxon10515 ncbitaxon10298 helper result formation antigen detect vp unit virion antiserum result suggest 333 8 9 cell enhance formation two three aav 3 structural polypeptide incomplete potentiation related ncbitaxon10310 genetic material possess cell
163320	1975	biochemical property ncbitaxon1891767 transform 3t3 cell mitochondrion mitrochondria isolated ncbitaxon1891767 transform 3t3 nontransformed 3t3 cell compare several biochemical measure transform nontransformed cell mitochondrion identical density additive meshd013395 discontinuous ncbitaxon9913 serum albumin gradient activity several mitochondrion specific enzyme include cytochrome oxidase adenylate kinase meshd009243 meshd009243 cytochrome reductase nadh oxidase similar cell type activity mitochondrial outer membrane enzyme monoamine oxidase virus transform cell mitochondrion reduce 50 nontransformed cell mitochondrion
163322	1975	cell origin meshd009369 induced ncbitaxon1891767 two meshd008223 induced ncbitaxon1891767 ncbitaxon1891767 ncbitaxon10036 study lymphocyte characteristic hymphocytes meshd009369 contain membrane bound immunoglobulin alone 7sgamma2 class neither meshd009369 complement receptor meshd009369 oringinated specific cell population suggest cell type associate ncbitaxon1891767 receptor
163324	1975	elevate immunofluorescence antibody titer several herpesviruses meshd002051 patient high titer alone antibody titer viral capsid antigen four human herpesviruses measure immunofluorescence serum 16 meshd002051 bl patient 16 age sex and locality equal control and 136 family member from the west nile zone uganda among family member titer great 1 4 found 98 herpes simplex virus meshc536395 86 ncbitaxon10335 ncbitaxon10335 100 for cytomegalovirus cmv and 94 for meshd020031 ebv titer patient medium approximately equal 2 log fourfold high equal control ebv ncbitaxon10335 cmv equal 0 001 titer meshc536395 slightly high meshd009369 patient generate patient someuhat high ebv titer 0 05 small equal low than or equal to 0 01 generate control difference patient control family found immunofluorescence method apparently use four human herpesviruses bl patient patient elevate antibody titer ebv cmv ncbitaxon10335 elevate titer three four human herpesviruses due serologic hybridization reaction
163325	1975	unexpected high incidence meshd006528 geneva switzerland age standardize incidence rate meshd006528 plc geneva 9 7 per 100 000 male form four five time high incidence rate report elsewhere europe plc much associate meshd005355 meshd000437 indicate toll plc related meshd000437 meshd008104 great anticipate
163326	1975	induction epstein barr virus associate nuclear antigen vitro transformation human lymphoid cell human lymphoid cell isolated peripheral blood adult cord blood fetal liver spleen bone substance thymus cultivate cell free preparation epstein barr virus ncbitaxon10376 demonstrate transform activity culture examine ncbigene17494235 transfromation permanent lymphoblastoid cell line lcl ncbigene17494235 see culture obtain exogenous ncbitaxon10376 detect day 1 6 addition ncbitaxon10376 often day 3 ncbigene17494235 positive cell lymphoblastoid appearance transformation establish lcl become apparent day 12 19 addition ncbitaxon3527 mitogen culture contain ncbitaxon10376 enhance development ncbigene17494235 whereas phytohemagglutinin concanavalin effect neither ncbigene17494235 transfomration observe lymphoid cell fetal thymus fetal spleen bone substance liver cell ncbitaxon10376 regularly induced ncbigene17494235 lcl transformation
163327	1975	isolation tropic type virus reticulum cell meshd009369 induced balb ncbitaxon10090 sjl type virus d1 ncbitaxon11786 mulv tropic type virus isolated spontaneous meshd008228 type rcn sjl ncbitaxon10090 circulate nih swiss ncbitaxon10090 embryo cell culture inject balb ncbitaxon10090 1 day neonatal thymectomy 30 inoculate ncbitaxon10090 developed rcn 5 month whereas none uninoculated control spleen lymph node extract rcn contain ncbitaxon10090 test tropic type virus show e1 mulv isolated high titer 10 5 minus 10 6 xc plaque form unit ml low titer 10 1 minus 10 2 xc plaque form unit ml tropic virus isolated thymectomized ncbitaxon10090 inoculate nontumorous whereas tropic virus detect uninoculated thymectomized ncbitaxon10090 virus isolated nonthymectomized untreated control antigenically viral envelope antigen ncbigene12515 e1 mulv distinct du mulv xvea gross ncbigene12515 hybridization reaction akr mulv ncbigene12515 observe relationship d1 mulv e1 muvl respect oncogenesis viral genome activation discuss
163328	1975	chromosome aberration ncbitaxon10036 embryo cell transform exposure ultraviolet irradiate ncbitaxon10298 2 6 ncbitaxon10036 embryo cell line 14 012 8 1 kos 6 1 333 8 9 333 2 29 ms 4 1 fr 6 1 developed exposure primary culture different strain uv irradiate herpes simplex virus hsv type 1 2 study chromosome aberration cell line show chromosome stability number chromosome maintain narrow range mutant diploid region low incidence polyploid endoreduplications metaphase pulveration extensively fragment chromosome cell line passaged long period time vitro developed marker chromosome suggest clonal type development cell population two cell line 333 8 9 14 012 8 1 show two different marker chromosome large heterochromatic region chromosome abnormal heterochromatic region much appear like large secondary constriction found cell line examine level chromosome breakage low cell line except highly tumorigenic cell line 333 2 29 high incidence cell single double chromatinic body abnormal heterochromatic region occur marker chromosome large secondary constriction see possible chromosomal effect hsv karyotypic stability low incidence give give result uv irradiation hsv
163330	1975	blood group mn antigen precursor normal malignant human breast glandular tissue blood group active substance demonstrate human mammary gland tissue benign malignant lesion precursor thomsen friedenreich antigen occur meshd009369 tissue found regularly 15 gross meshd009369 test precursor tn antigen found regularly meshd009369 breast tissue antigen reactive breast meshd002278 antigen demonstrable 6 benign mammary gland study similarly tn antigen unmasked sialidase treatment healthy breast tissue anti antibody present human serum severely low many meshd001943 patient compare control
163331	1975	quantitative autoradiographic study nucleolus associate rna dna synthesis eclipse phase meshd001357 ncbitaxon9031 fibroblast functional morphological difference sensitivity nucleolus ncbitaxon11886 transform cell new infect cell action meshd003609 meshd000544 demonstrate quantitative light electron microscope autoradiography use investigate function nucleolus early stage meshd007239 pulse exposure low cause meshd000544 increase rna synthesis induced 80 hour fibrillar component nucleolus meshd007239 concomitant increase retention tritiated meshd000544 nucleolus quantitative redistribution intranuclear cytoplasmic dna label see evidence virus induced amplification binding site meshd000544 nucleolar chromatin
163332	1975	effect ncbitaxon1891767 subcutaneous meshd009369 circulate meshd008055 lipoprotein ncbitaxon10036 circulate meshd008055 level lipoprotein normal ncbitaxon10036 determine several time subcutaneous inoculation ncbitaxon1891767 ncbitaxon1891767 strain 2895 fortner meshd008545 cell ncbitaxon1891767 omim102510 induced rapid triphasic peak serum total meshd008055 inhibition prebeta lipoprotein catabolism alpha lipoprotein level decline ratio meshd009369 mass liver wet weight total meshd008055 substance increase significantly normal rate 3h glycerol incorporation meshc009791 precipitable prebeta serum lipoprotein maintain finding serum endogenous lipase lecithin cholesterol acyltransferase lcat cholinesterase activity indicate enzyme primarily responsible meshd009369 induced meshd006949 tumor contain animal selectively increase rate protein meshd008055 excretion urine evidence gross hepatocellular meshd007674 growth ncbitaxon1891767 2895 meshd009369 hamster result large increase rate prebeta lipoprotein synthesis degradation circulate prebeta lipoprotein level elevate much later animal subsequent label decrease lcat activity rather different result obtain meshd008545 level large meshd009369 control effect serum total meshd008055 level lipoprotein normal ncbitaxon10036
163333	1975	inhibition cellular immune response ncbitaxon1891767 meshd009369 cell meshd009369 contain meshd009369 immune ncbitaxon10090 concanavalin effect vivo administer concanavalin con kinetics primary secondary cellular immune response ncbitaxon1891767 transform meshd009369 cell investigate balb ncbitaxon10090 either single initial dose 400 mug con daily cause 50 mug low cell mediate immune response meshd009369 cell progressive growth meshd009369 determine radioisotopic base pad assay immune meshd000275 correlate increase ultimate meshd009369 weight similarly con inhibit antitumor cellular immune response meshd009369 immune animal immune responsiveness give 6 day single injection 400 mug con continuous administration 50 mug con result gradual decline antitumor cellular immune responsiveness reach plateau 5th day splenic lymphocyte con treat immune ncbitaxon10090 fail extract local adoptive change reaction immune responsiveness tend give incubation alpha methyl pyranosyl sugar
163334	1975	property ncbitaxon9031 lymphoblastoid cell line meshd008380 property ncbitaxon9031 lymphoblastoid cell line msb 1 meshd008380 study cell line grow well 41 degree medium rpmi 1640 supplement 10 ncbitaxon9913 fetal serum double time 8 12 hour cell grown stationary suspension culture bind vessel morphology typical lymphoblast 37 degree cell line grow initially cease fraction several subculture subculture maintain 48 72 hour 1 2 cell produce ncbitaxon10390 ncbitaxon10390 specific intracellular mambrane antigen contain ncbitaxon39059 particle examine electron microscope cocultivation cell duck ncbitaxon9031 embryo fibroblast culture result meshc564591 production microplaques typical ncbitaxon10390 peripheral nerve lesion meshd009369 characteristic marek meshd010300 cause inoculation susceptible chick msb 1 cell duck cell infect strain bc 1 ncbitaxon10390 find msb 1 cell line specific meshd009369 produce site inoculation meshd007239 readily transmit cagemates meshd009369 produce skeletal muscle appear largely virus induced msb 1 cell line free type virus particle
163335	1975	estrogen dependent vitro stimulation rna synthesis hormone dependent mammary meshd009369 ncbitaxon10116 incubation estradiol vitro 25 degree homogenate carcinogen induced mammary meshd009369 ovariectomized ncbitaxon10116 stimulate meshd008274 dependent rna polymerase activity nucleus hormone dependent meshd006816 regress meshd009369 effect activity nucleus hormone autonomous hi grow meshd009369 recombination nucleus cytosol fraction meshd006816 meshc538424 indicate vitro effect meshd004958 subsequent meshd009369 nuclear rna synthesis require ncbigene24890 contain cytosol specific nucleus meshd006816 found first direct vitro effect estrogen specific biochemical process meshd006816 mammary meshd009369
163336	1975	meshd008223 associate ncbitaxon10381 ncbitaxon9505 two case meshd008223 one case meshd008232 found group 7 ncbitaxon9505 implication colony single group ncbitaxon10381 ncbitaxon10381 isolated meshd009369 cell 1 meshd008223 cocultivation kidney cell culture imp meshd008232 antibody ncbitaxon10381 found serum sample 2 imp positive ncbitaxon10381 serum 4 clinically normal imp antibody meshd020031 cell found serum animal meshd008223
163337	1975	virus envelope marker mammalian tropism avian rna meshd009369 virus pseudotypes ncbitaxon11276 make avian meshd001357 present five different subgroup pseudotypes show host range restrict avian meshd009369 virus assay avian cell neutralize subgroup specific antiserum efficiency penetration mammalian cell assay use ncbitaxon11276 pseudotypes pseudotypes avian meshd009369 virus belonging subgroup b77 virus able plate mammalian cell high efficiency whereas pseudotypes strain efficiency penetration ncbitaxon11276 pseudotypes 10 2 10 3 fold high efficiency transformation correspond avian meshd009369 virus strain assay mammalian cell suggest postpenetration block expression transformation cell
163344	1975	rna synthesis cell infect herpes simplex virus 9 evidence accumulation abundant symmetric transcript nucleus rna extract nucleus 8 infect cell take approximately 50 herpes virus dna dna rna hybrid rna preannealed condition provide base pair study rate take 35 dna dna rna hybrid anneal rna decrease amount rna sequence remain available subsequent hybridization dna upon denaturation preannealed rna rna sequence sequester preannealing become available hybridization dna base pair occur preincubation rna inter molecular since rna concentration dependent involve determine alkaline hydrolysis nuclear viral transcript remain available hybridization preannealing rna subset rna sequence accumulate cytoplasm infect cell addition small amount derive 5 less viral dna complementary transcript detect cytoplasm
163347	1975	meshd003513 induction xenotropic type virus synchronize ncbitaxon10090 cell metabolic requirement virus activation information type rna virus genetically transmit cellular dna normal ncbitaxon10090 cell virus induced exposure cell two class chemical inhibitor protein synthesis halogenated meshd011743 metabolic requirement activation one endogenous virus balb ncbitaxon10090 cell representative class dose study meshd003513 meshd007065 induce virus efficiently culture exponential growth inactive cell stationary phase cell maximally sensitive action dose different time cell cycle virus induction response differentially inhibit condition simultaneous cell exposure inhibitor dna rna synthesis result provide support concept inhibitor protein synthesis halogenated meshd011743 number different mechanism induce type virus free
163363	1975	meshd001102 antigen synthesis modify meshd005166 cell transform t mutant ncbitaxon10090 cell transform t mutant meshd001102 t 3t3 low amount virus specific antigen synthesize high temperature 39 shift permissive temperature 31 cell exhibit level antigen production wild type polyoma transformants antigen produce t transform cell inactivate 39 vitro fast rate produce wild type transform cell observation indicate antigen include virus cod peptide
163364	1975	malignant transformation ncbitaxon10034 kidney cell ncbitaxon1891762 primary ncbitaxon10034 kidney cell transform ncbitaxon1891762 new human papovavirus transform hkbk cell produce ncbitaxon1891762 antigen induced meshd009369 hamster developed antibody ncbitaxon1891762 antigen ncbitaxon1891762 rescue hkbk cell ncbitaxon11191 assist fusion permissive cell one 6 cell line derive hkbk cell induced meshd009369 show characteristic hkbk cell
163369	1975	quantitative assay transformation 3t3 cell ncbitaxon10310 interaction ncbitaxon10298 hsv 1 type 2 ncbitaxon10310 swiss 3t3 cell investigate virus induced cytopathic effect developed absence production infectious virus ncbitaxon10310 inactivate uv light 2 4 6 8 min induced cell death absence virus replication cell death detectable infection ncbitaxon10310 inactivate uv irradiation 10 12 14 min 3t3 cell infect uv inactivate virus 10 12 min remain double past reach inhibit monolayer usually associate cell infection 3t3 cell uv irradiate usv 2 induced development transform focus transform cell epithelioid fibroblastoid morphology identify isolated ncbitaxon10310 transform cell line contain ncbitaxon10310 specific antigen detectable immunofluorescence technique maximal frequency ncbitaxon10310 induced transformation 3 time 105 pfu per transform focus observe transformation inhibit pretreatment virus specific antiserum type particle detect five cell culture passage transformation ncbitaxon10310 type virus particle detect 10 cell culture passage ncbitaxon10310 transform cell line
163372	1975	interspersion sequence ncbitaxon11866 rna rapidly hybridize meshd007938 ncbitaxon9031 cell dna fluid hybridization progressively small fragment 35s 27s 15 5 12 5 8 poly select ncbitaxon11866 rna excess dna meshd007938 ncbitaxon9031 myeloblast reveal size rna contain sequence complementary slow rapidly hybridize cellular dna sequence apparently rna sequence hybridize rapidly excess cellular dna restrict one region ncbitaxon11866 35s rna rather appear randomly circulate total 35s ncbitaxon11866 rna particle set 200 base meshd011061 tract 3 last rna
163374	1975	ncbitaxon1891767 function require administration maintenance malignant transformation member five class temperature sensitive ncbitaxon1891767 mutant test ability transform ncbitaxon10029 lung cell two measure transformation use ability form clone medium low serum concentration ability overgrow monolayer mutant fail transform restrictive temperature subconfluent ncbitaxon10029 lung monolayers use mutant fail transform restrictive temperature confluent monolayers deplete medium use transform clone select purify recloning examine temperature cell line induced mutant lose transform phenotype high temperature function require maintenance transform phenotype ncbitaxon10029 lung cell function know require induction viral dna synthesis permissive cell therefore transformation result presentation cell capacity aberrant induction dna replication
163375	1975	function ncbitaxon1891767 gene transform infection productive infection ncbitaxon1891767 gene know determine induction viral dna replication control synthesis late viral rna function gene transform infection investigate infection form cell specie 6 independently isolated temperature sensitive mutant belonging complementation group mutant fail initiate stable transformation cell continuous infection restrictive temperature administration transformation permissive temperature subsequent shift restrictive temperature block function two distinct virus cell interaction identify one case increase colony form capacity transform cell remain stable temperature shift case temperature shift decrease capacity transform cell form colony level untransformed control cell result virus cell interaction count nature mutant give cell specie specie cell transform give mutant finding suggest transformation process require two distinct case related gene expression
163376	1975	role ncbitaxon1891767 gene function maintenance transformation ncbitaxon10090 ncbitaxon10034 human cell transform permissive temperature mutant ncbitaxon1891767 ncbitaxon1891767 complementation group rate control role gene function transformation follow parameter transformation monitor transform cell permissive nonpermissive condition morphology saturation density colony formation plastic cell monolayers diffuse meshd000362 uptake meshd006601 expression meshd009369 surface antigen cell transform temperature sensitive t mutant exhibit phenotype transform cell nonrestrictive temperature parameter study grown restrictive temperature phenotypically similar normal untransformed cell growth curve show t mutant transform cell exhibit growth characteristic wild type virus transform cell permissive temperature resemble normal cell rate restrictive condition 3 51 fold reduction level saturation density colony formation uptake meshd006601 mutant transform cell elevate temperature compare grown permissive temperature mutant transform cell nonpermissive temperature able produce transform focus shift permissive condition indicate phenotypically revert cell inactive viable regress reversible case ncbitaxon1891767 antigen present cell temperature antigen detect cell maintain nonpremissive temperature wild type virus transform cell exhbited transform cell exhibit transform phenotype grown either restrictive nonrestrictive condition thers result indicate ncbitaxon1891767 group mutant transform cell temperature sensitive maintenance growth property characteristic transformation virus rescue mutant transform cell transfection method t suggest ncbitaxon1891767 gene function rather cellular one responsible t behavior cell
163377	1975	ncbitaxon1891767 gene function maintenance transformation transformants isolated infection ncbitaxon10116 embryo cell 33 either wild type ncbitaxon1891767 temperature sensitive gene mutant tsa7 tsa28 examination property usually associate transformation growth 1 serum growth rate saturation density morphology show property temperature dependent meshc012589 transformants characterize temperature dependent wild type transformants examine good characterize tsa transformants expression antigen appear temperature dependent information suggest active function require maintenance transformation cell lytic cycle function involve induction dna synthesis transformation ncbitaxon1891767 direct result presentation ncbitaxon1891767 replicon presence dna initiator function cause cell show transform phenotype
163379	1975	detection virus specific antigen surface herpes simplex virus transform cell virion associate antigen cp 1 detect surface ncbitaxon10034 cell transformation inactivate ncbitaxon10298 presence cp 1 antigen cell correlate synthesis antibody tumorbearing hamster able neutralize herpes simplex virus type 1 2
163380	1975	ectopic production ncbigene2056 meshd009396 patient relation clinical stage disease activity measurement ncbigene2056 level reach urine plasma meshd009369 extract specimen 27 meshd009396 patient good correlation stage disease clinical judgment inactive respond meshc565785 ncbigene2056 level line ncbigene2056 level believe reflect ectopic hormone production primary secondary meshd009369 since ncbigene2056 hormone assay meshd009396 patient associate meshd011086 believe meshd009396 associate ncbigene2056 differ manner hormone produce usually human possible state associate secondary meshd011086 etythropoietin assay purification technical development additional widespread assistance clinical classification subsequent management meshd009369 state study support biological possible
163448	1975	computerize axial tomography clinicopathologic correlation august 1973 april 1974 750 patient computerize axial tomography ct scan massachusetts general hospital ten brain previously ct scan patient group section level scan nearly take correlation found anatomic location extent intracranial lesion demonstrate ct scan finding gross microscopic pathologic examination case primary meshd001932 meshd006849 meshd002543 meshd007511 meshd002544 meshd010871 thermal burn meshd001927 finding concentration value mu 47 pathologically control process show high concentration meshd002543 meshd002118 contain meshd009369 readily separable process base mu value alone abnormal mu value primary meshd001932 meshd004487 meshd007238 difficult differentiate normal spinal fluid white count
163453	1975	isolation herpes simplex virus cerebrospinal fluid meshd008587 two case meshd008581 report etiologic diagnosis establish isolation herpes simplex virus cerebrospinal fluid patient afebrile meshd001919 culture obtain one patient mean meshd007938 see total others literature show value culture herpes simplex virus cerebrospinal fluid
163460	1975	odontogenic meshd018254 comprehensive study 20 new case 20 new case meshc538229 total literature take total number report case 152 clinical radiographic microscopic finding case support previously report information lesion odontogenic meshd018254 benign lesion grow residue odontogenic epithelium treat conservatively indication lesion repeat histogenesis lesion well origin esinophilic droplet material discuss
163461	1975	meshc538445 submandibular gland meshc538445 major salivary gland observe report literature much site origin primary meshd009369 skin mucosal line direct neck structure meshd009369 usually meshd008545 meshd002294 often involve salivary gland parotid submandibular sublingual gland rarely involve meshd004194 secondary lesion grow distant primary meshd009369 occasionally involve parotid gland highly rare major salivary gland second report case metastatic meshd002277 submandibular gland present case previously report case similar primary meshd009369 grow breast clinical morphological feature review
163487	1975	survival form meshd016399 adenylate cyclase meshd007545 stimulator adenylate cyclase use select stable form clone ncbitaxon10090 meshd008228 enzyme inability four different stimulators activate meshd000242 synthesis form contrast wild type parent involve normal cell one type adenylate cyclase molecular respond different activator
163489	1975	primate type virus ncbigene201161 antigen cell human meshd015470 antigen related major structural protein ncbigene201161 type virus isolated ncbitaxon9519 ncbitaxon9581 ape found peripheral white blood cell five patient meshd015470
163501	1975	mesothelial reaction meshd001195 irritant intraperitoneal injection ten group ncbitaxon10116 inject intraperitoneally one follow suspension measure source meshd017638 ii acid treat meshd017638 3 meshd017638 plus meshc000499 4 meshd017638 plus meshd012822 meshc000499 6 meshd012822 7 long fibre meshd017638 8 short fibre meshd017638 9 long fibre glass short fibre glass two ncbitaxon10116 group kill 45 xc 150 240 330 day respectively pathology induced different suspension study histologically time interval evidence support chemical induction theory mechanical irritation theory pathogenesis peritoneal meshd008654 found although suspension except meshc000499 cause reactive mesothelium
163502	1975	technique result endoscopic retrograde pancreaticocholangiography preliminary report 140 patient endoscopic retrograde pancreaticocholangiography erpc perform 140 patient primarily black indian first 100 patient study great diagnostic production series suspect obstructive meshd007565 26 diagnosis make 35 patient 40 patient meshd010195 wide duct see 12 patient meshc566837 procedure less helper require patient meshd010146 cessation meshd000438 uptake found operable stricture primary meshd021441 pancreatic function test secretin cholecystokinin pancreozymin correctly diagnose 4 patient meshc566837 erpc normal useful diagnostic production patient meshd012817 15 diagnosis make 23 patient
163509	1975	ultrasound diagnosis meshd006869 due obstruction pelviureteric junction use ultrasound diagnosis upper abdominal mass nonfunctioning kidney described two case congential meshd006869 due obstruction pelviuretic junction present diagnose scan ultrasound examination diagnostic ultrasound simple noninvasive reliable method differentiate cystic solid lesion value whether mass renal extrarenal recommend patient see upper abdominal mass nonfunctioning kidney examine ultrasound
163515	1975	meshd016582 clinical effect ncbitaxon9685 meshd016582 common among ncbitaxon9685 reach high virus transmit readily ncbitaxon9685 cause form haemopoietic meshd008223 common type alimentary multicentric thymic meshd015451 virus involve aetiology certain disease include meshd000740 meshd005921 meshd013577 predisposes ncbitaxon9685 intercurrent meshd007239 many infect ncbitaxon9685 rise immune response support immune condition show serum antibody level feline meshd007938 virus associate cell membrane antigen ncbitaxon9685 titer 32 unlikely support ill effect eliminate meshd015658 result meshd007239 single cat count immunological competence cat dose virus obtain ability induce immunosuppression ncbitaxon11768 meshd007239 detect examination tissue electron microscopy culture virus plasma tissue link state method use detection meshd007938 antigen peripheral blood leukocyte contain average blood take successful prototype vaccine developed ncbitaxon11768 report line natural history virus disease implicate discus late developed diagnostic method
163523	1975	mixed mullerian meshd009369 uterus ultrastructural study differentiation rhabdomyoblasts present study differentiation rhabdomyoblasts two meshd002296 uterus study electronmicroscopically development rhabdomyoblasts three cell type differentiate 1 undifferentiated mesenchymal cell abundant ribosome cell organelle usually cell already associate strand 2 4 cell occasionally cytoplasmic region numerous nonspecific strand observe 2 light rhabdomyoblast characterize conspicuous nonspecific cytoplasmic strand reduction ribosome specific myofilaments see occasionally cell type 3 differentiate rhabdomyoblasts cell identify clearly presence large number myofibril myofibrillar fragment higly form myofibril see skeletal muscle seldom found transitional form cell type observe function body sarcotubular system process myofibrillar differentiation discuss
163559	1975	cytopathology metastatic meshd001943 comparison make histopathologic cytopathologic appearance 45 case metastatic meshd001943 histopathologic appearance primary meshd009369 metastatic infiltrate duct meshd002277 body cavity fluid present admixture single cell tissue fragment ratio 0 86 1 usually occur tissue fragment well limited cycle oval mass cell true acinus cell tandem system cell metastatic infiltrate duct meshd002277 pleomorphic range 11 5 22 micrometer diameter metastatic infiltrate meshd018275 body cavity fluid present population primarily single cell ratio 13 single cell tissue fragment rare tissue fragment see group generally cohesive cell nuclear form cytoplasm adjacent cell single cell highly high nuclear cellular ratio undifferentiated size range diameter 10 5 14 micrometer presentation metastatic infiltrate meshd018275 similar meshd008223 body cavity fluid cerebrospinal fluid present problem differential diagnosis
163565	1975	virilize meshd018246 reactive gonadotrophin virilize meshd018246 demonstrate yound female urinary meshd015068 excretion subfractions plasma meshd013739 level urinary 17 ketogenic meshd013256 excretion markedly increase meshd003687 primary component androgen excess otherwise meshd018268 found normal evaluate measurement meshd006854 meshd003345 metabolite basal condition active test androgen excess show unexpected response trophic hormone human chorionic gonadotrophin stimulation result label increase androgen production whereas gonadotrophin colony demonstrate mean estrogen inhibition test similarly corticotrophin colony demonstrate corticotrophin stimulation inhibition test removal meshd009369 result normalization androgen production abnormal response upon human chorionic gonadotrophin administration found inappropriate response meshd009369 trophic hormone discuss conclude reliability stimulation inhibition test determine site excessive androgen production take reservation
163566	1975	dissociation vivo vitro autonomy human meshd000306 diagnosis meshd003480 due meshd000306 establish patient appropriate examination especially meshd003907 inhibition test ncbigene5443 stimulation test ncbigene5443 measurement radioimmunoassay isolated cell make man meshd009369 trypsin technique action ncbigene5443 steriodogenesis cell study vitro basal production corticosteroid isolated meshd009369 cell low 0 3 mu plus minus 0 04 2 10 5 cell addition ncbigene5443 induced dose dependent stimulation corticosteroid production meshd009369 cell appear unable produce corticosteroid absence ncbigene5443 maximal production rather low 1 38 mu plus minus 0 07 2 10 5 cell possible explanation variant hormone function test result vitro study give
163571	1975	bronchiolo meshd002282 cell origin bronchiolo meshd002282 least common primary meshd008175 controversy cell origin light electron microscopic study five bronchiolo meshd002282 least two cell type found bronchiolar origin one cell type metaplastic bronchiolar mucous cell bronchiolar base cell ultrastructural feature respiratory ciliated respiratory nonciliated clara cell unusual meshd009369 bronchiolo alveolar region differentiate cell either bronchiole alveolus embryologically common origin information ultrastructure meshd009369 accumulates become apparent meshd002282 must rare occurrence hyperplastic type ii aleveolar epithelial cell found margin meshd009369 mistaken neoplastic cell
163577	1975	role renal meshd000242 control ncbigene13856 production regulatory role meshd000242 meshd000242 production renal hormone rythropoietin follow erythropoietic stimulation cobaltous chloride hexahydrate suggest study rate reveal temporal relationship renal meshd000242 level plasma titer ncbigene13856 addition meshd003035 increase activity ncbigene13856 give enzyme renal erythropoietic factor maximal enzyme activity occur surface meshd000242 level increase ncbigene13856 titer increase renal meshd000242 set renal cortex meshd003035 stimulate renal cortical adenylate cyclase effect renal cyclic base phosphodiesterase addition meshd000242 3 time 10 6 partially purify cyclic amp dependent protein kinase ncbitaxon10116 kidney inactive preparation renal erythropoietic factor increase ability renal erythropoietic factor give ncbigene24335 information polycythemic ncbitaxon10090 assay bioassay use quantitate erythropoietic activity test substance indicate meshd003994 erythropoietically active respect ability increase radioactive label meshd007501 meshc000615388 incorporation meshd006418 new form red blood cell meshd013806 erythropoietically inactive potentiate erythropoietic effect meshd003035 polycythemic ncbitaxon10090 result suggest meshd000242 represent significant role renal production ncbigene13856 follow meshd003035 administration require meshd003035 stimulate renal cortical adenyoate cyclase increase renal meshd000242 level meshd000242 activates protein kinase later stimulate renal erythropoietic factor give ncbigene13856 similar meshd000242 mechanism surgical erythropoietic stimulation exposure meshd000860 meshd011453 treatment
163581	1975	american meshd002051 clinicopathologic study 30 case ii pathologic correlation 30 case meshd008223 undifferentiated burkitt type review old average age predominance presentation abdominal pelvic site rather jaw differentiate series american patient report endemic region africa bone substance involvement invariably consist massive infiltration recognizable smear clot biopsy preparation involvement central nervous system meshd001855 always associate short survival 8 long term survivor meshd008223 apparently restrict single site presentation autopsy consistent detect widespread multiorgan involvement predilection lymphoreticular structure histologic appearance meshd009369 change chemotherapy vary circulate meshd009336 48 hour initial therapy extreme pleomorphism meshd009369 cell 9 month therapy one patient almost gross meshd004832 autopsy organ site show clinically extensively involve meshd009369 prior treatment diagnostic therapeutic implication finding discuss
163582	1975	clinical evaluation patient meshd007244 development antibody component epstein barr virus induced early antigen complex old report emphasize transitory antibody response epstein barr virus ncbitaxon10376 induced early antigen ea course meshd007244 usually direct circulate component ea complex report clinical serologic information present 14 patient meshd007244 respond either alone antibody restrict component ea complex reveal anti initial anti response subside week month onset disease anti remain usually many month many 39 patient long detectable late follow serum spectimens although many patient unremarkable course illness others largely late anti response show unusual prolong clinical expression several complain period 4 28 month recurrent symptom resemble see acute stage disease presence anti relatively high continuous titer antibody eb viral capsid antigen vca reflect common persistent ncbitaxon10376 activity number report recurrent symptom
163583	1975	meshd005198 adult expression latent form meshd009101 review 17 case meshd005198 bence jones meshd011507 meshd009101 meshd000686 include three new case report detail emerges well determine determine characteristic case diagnosis meshd005198 precede development meshd000686 meshd009101 precede development meshd005198 report patient bence jones meshd011507 detect electrophoresis immunoelectrophoresis 7 case bence jones protein type kappa type serum protein monoclonal abnormality bone substance renal sample half patient crystalline cytoplasmic inclusion body present lymphoplasmacytic component renal tubular cell suggest patient meshd005198 bence jones meshd011507 distinct type plasma cell disorder form monoclonal gammopathy characterize slow progression meshd009369 early phase dominate metabolic complication meshd005198 adult patient meshd005198 carefully investigate presence bence jones protein plasmacytic meshd010265 exclude
163584	1975	aberrant hormone activity meshd009369 gynecologic importance increase number meshd004701 report production hormonal substance generally associate tissue involve direct indirectly interest gynecologist identification occurrence significant diagnosis meshd009382 meshd009369 effect addition observation level aberrant hormone secretion significant therapeutic prognostic measure detection result investigation apparent inappropriate meshd004700 function test case know meshd009369 proof actual production hormone meshd009369 gross identification material question generally require wide biological chemical physical immunological investigation likely mechanism aberrant hormone production meshd009369 derepression genome occurrence find biosynthetic anomaly coincident neoplastic nuclear alteration hormone active substance interest gynecologist produce condition include gonadotrophin lactogen thyrotropin adrenocortico tropin well meshd002118 circulate erythropoietic substance
163585	1975	ncbigene1084 patient gynecologic meshd009369 finding ncbigene1084 ncbigene1084 plasma much interest currently concomitant search immunological diagnosis test late report shed doubt specificity carcinoembryonic antigen meshd004067 report detail plasma ncbigene1084 value 341 patient vary gynecologic meshd009369 study demonstrate plasma ncbigene1084 elevate fold 50 per cent patient invasive gynecologic meshd009369 incidence positive value appreciably high elevate stage disease specific interest 84 per cent 21 25 patient recurrent meshd002294 neck positive ncbigene1084 value similar result found patient meshd009369 vulva ovary endometrium
163592	1975	human meshd050197 plaque cell meshd007889 cell comparison vitro growth characteristic cell derive human meshd050197 arterial medium compare cell obtain human meshc535516 myometrium respect growth behavior long term cell culture none numerous mutant culture medium include alteration serum concentration origin improve rate cell multiplication vitro longevity uterine cell type neither arterial cell type multiply tissue dissociation enzyme elastase collagenase hyaluronidase replicative living pair 8 sample arterial plaque cell equal less correspond median cell similar relationship observe 8 pair determine meshd007889 myometrial cell result indicate condition culture vitro cell bona fide fluid meshd009217 finite replicative living pair fluid muscle cell meshd050197 plaque act similar manner
163597	1975	roentgen problem evaluate atrophic support elderly gastric meshd001284 elderly cause problem interpretation gastrointestinal study 17 case report 8 patient show determine distensibility irregularity distal support copy meshd002293 6 patient show meshd016055 2 patient show meshd016055 medium awareness phenomenon prevent good error roentgen diagnosis
163611	1975	meshd007340 low circulate ncbigene3630 level diagnostic value ncbigene3630 measurement meshd007003 coexist low plasma immunoreactive ncbigene3630 concentration found 78 year old woman meshd007340 absolute ncbigene3630 level meshd007003 elevate 0 9 1 4 ng ml report 66 5 total circulate immunoreactive insulinlike material produce serum ncbigene3630 concentration together abnormal ncbigene3630 ncbigene3630 ratio show critical importance establish diagnosis islet cell meshd009369 patient
163619	1975	mummify cutaneous mixed meshd009369 34 year old human unusual mummify cutaneous mixed meshd009369 developed short meshd014947 apocrine type meshd009369 cell pilar differentiation explain presence mummification
163621	1975	intracavitary cardiac reference meshd006528 acute meshd059446 62 year old human demonstrate angiographically due meshd009369 later show metastatic meshd006528 resection meshd009369 result total diagnostic rest
163628	1975	histocompatibility antigen solid meshd009369 evaluate relation histocompatibility antigen phenotype solid meshd009369 hl type determine 633 meshd009369 patient compare 489 normal control hl a8 elevate patient meshd002294 meshd008545 meshd000230 high incidence occur patient meshd012468 67 5 17 normal control double increase hl a5 detect patient connective tissue meshd012509 28 incidence 5 9 normal control antigen frequency vary study time diagnosis interval treatment detect certain meshd009369 association increase frequency single hl antigen give clue cause genesis meshd009369
163633	1975	islet cell meshd010190 30 case meshd018273 diagnose memorial hospital study 17 male 13 female patient medium age 44 year meshd009369 site body tail pancreas 25 case primary meshd009369 large 6 cm epigastric meshd010146 meshd007003 meshd007565 frequent primary clinical presentation morphological difference found function nonfunctioning meshd009369 size meshd009369 local tissue infiltration vascular invasion helpful absolute parameter aid differentiation benign meshd018198 20 6 patient metastatic disease time diagnosis liver regional lymph node bone peritoneum common site meshd009362 medium survival 3 9 year cumulative five year survival rate 65
163642	1975	general expression hydrophobic chromatography adsorption elution characteristic skeletal muscle enzyme degree substitution meshd012685 4 alpha alkylamines change gel different hydrophobicity produce protein adsorbed critical hydrophobicity ca 10 12 alkyl residue meshd012685 area reach enzyme phosphorylase kinase phosphorylase phosphatase 3 5 camp dependent protein kinase glycogen synthetase phosphorylase successively adsorbed hydrophobicity meshd012685 increase capacity gel enzyme protein general increase exponentially reach plateau value function degree substitution indication restriction hydrophobic substance give protein critical hydrophobicity require adsorb protein either otained manner elongation use alkylamine constant degree substitution additonally hydrophobicity gel increase high binding effect result desorption protein require augmentation meshd012492 concentration elution buffer elution protein hydrophobic matrix described term salt phenomenon since desorption dependent type meshd012492 use ionic strength alone normal ionic interaction major factor adsorption per se rationally control hydrophobicity meshd012685 gel adsorption elution protein establised purification excretion optimally perform
163652	1975	dna binding protein novikoff meshd006528 cell 0 05 meshd012965 6 8 total soluble protein novikoff meshd006528 cell bind rapidly reversibly column contain either heterologous homologous dna adsorbed meshd002482 protein elute buffer contain 2 0 meshd012965 0 5 1 total protein exhibit 7 17 fold preference ncbitaxon10116 dna ncbitaxon562 dna 1 1 5 protein bind dna strongly elution effect 4 0 meshd012965 action deoxyribonuclease treatment column dna binding protein elute 2 0 meshd012965 label 125i 131i characterize meshd012967 meshc016679 gel electrophoresis isoelectric focus experiment indicate dna binding protein present distinct subset total soluble protein many similarity line major component homologous heterologous dna binding fraction
163656	1975	three dna polymerase ncbitaxon10116 meshd001201 cell property enzyme effect rna synthesis reaction three different dna polymerase isolated ncbitaxon10116 meshd001201 cell 1 3 molecular weight dna polymerase polymerase purify soluble fraction cell estimate 142 000 sedimentation meshd013395 gradient molecular weight two dna polymerase polymerase 1 2 purify nuclear membrane chromatin fraction estimate 117 000 44 000 respectively method certain condition meshd011071 strand meshc015465 meshd013936 transcript well polymerase especially nuclear polymerase meshc023826 good template high molecular weight dna polymerase 1 meshd011071 meshc015465 good template addition complementary meshd009843 single strand deoxypolymers transcript high molecular weight polymerase 1 single strand fd phage dna use template polymerization reaction high molecular weight polymerase stimulate concomitant synthesis rna show oligoribonucleotide number primer reaction
163658	1975	human chronic meshd007951 cell line positive philadelphia chromosome cell line derive patient meshd015464 cml described new cell line 175 serial passanges 3 1 2 year period follow characteristic 1 cml cell first proliferate actively since first incubate culture medium double increase total number cell observe first 7 passage cell population increase factor 10 20 every 7 day passage 8 85 20 40 time passage 86 150 40 time 150 passage 2 majority nononucleated cell undifferentiated blast 3 karyotype cell examine show philadelphia ncbigene189 chromosome long acrocentric marker plus meshd000782 giemsa banding study identify ncbigene189 chromosome last deletion long arm chromosome 22 del 22 q12 long acrocentric marker unbalanced reciprocal translocation one chromosome 17 long arm one chromosome 15 4 cml cell produce immunoglobulin free meshd009175 epstein barr virus herpes like virus particle 5 cml cell alkaline phosphatase myeloperoxidase activity engulf inert particle 6 culture cml cell provide constant origin specific antigen cml cell line present alone origin cml cell meaningful indicator meshd009369 clinical experimental study
163662	1975	ultrasound monitor hepatic meshd009362 chemotherapy grey scale ultrasound found sensitive method detect metastatic disease liver two case result chemotherapy monitor ultrasound response treatment differentiate non response ultrasound give useful information chemotherapy make radioisotope examination unreliable
163673	1975	multiple chemotherapeutic approach management meshd018197 preliminary report 1970 stag base surgical resectability meshd056486 devise adjuvant chemotherapy meshd014750 meshd005472 meshd003520 give 7 late case target study determine unified clinical stag review evaluate effect combination chemotherapy survival elevate disease evaluate early adjunctive combination chemotherapy surgically resectable lesion hopefully prevent metastasis result see 7 patient change short prognosis three female patient present stage 3 4 meshd006528 three male stage ii meshd018197 cause well last free disease 47 month 44 month 28 month one patient meshd018197 lung metastasis diagnosis fail 7 month meshd009369 meshd064420 line use adjunctive combination chemotherapy follow major hepatic resection
163675	1975	clinical test oral form meshd005047 nsc 141540 vp 16 213 clinical test oral form vp 16 213 nsc 141540 semisynthetic meshd011034 undertaken 20 patient treatment first 200 mg day 5 day course double remain period 16 day five patient treat dose double 9 day remain period later 65 patient give 300 400 mg day 5 day remain period 9 day course side effect see include meshd000855 meshd009325 meshd014839 meshd013280 meshd003967 meshd007970 meshd013921 alopecia meshd011537 substernal discomfort palpitation report 18 patient explanation symptom found gross remission cr observe parital remission pr improvement imp see follow small cell meshd002277 lung 10 patient 2 pr 3 imp meshd000230 lung 4 patient 1 pr meshd002282 lung 1 patient 1 imp meshd008654 4 patient 1 imp meshd010051 12 patient 3 pr 3 imp meshd001943 20 patient 4 imp meshd015179 8 patient 2 imp meshd001749 4 patient 2 imp meshd016403 7 patient 2 pr 3 imp meshd015464 1 patient 1 imp
163676	1975	yoshi 864 nsc 102627 meshd000433 3 3 iminodi dimethanesulfonate ester hydrochloride phase 1 study yoshi 864 give push daily time 5 6 week review dose escalation 0 25 mg kg 2 7 mg kg meshd064420 effectiveness first see 1 5 mg kg 20 five course give 16 patient level 16 22 course single meshd015464 meshd013921 meshd007970 occur mean platelet leukocyte nadir occur day 24 29 recovery study 1 2 week 2 3 week respectively hb decrease 11 course 2 7 mg kg meshd009325 meshd014839 last 6 12 day occur 3 7 course 5 coures patient slept 20 hour day 1 meshd003128 2 day two patient meshd002294 1 unknown primary respond patient meshd015464 clinical remission recommend cooperative phase ii study wide spectrum human meshd009369 include meshd008223 meshd015464 undertaken dose level 2 mg kg
163677	1975	meshd004194 child retrospective review clinicopathologic correlation dietary management clinicopathologic feature meshd004194 review 44 child obtain unit abdominal irradiation therapy 1961 1972 institut gustave roussy five 14 long term survivor 36 developed severe delayed meshd011832 meshd007409 occur 2 month completion irradiation previously acute irradiation reaction therapy histologic appearance small bowel time delayed meshd011832 reveal severe meshd014949 lymphatic dilatation moderately slow inflammatory infiltrate patient delayed meshd011832 show label clinical improvement coincident fractionate low residue low fat diet free gluten free milk milk production meshd015212 roentgenographs small bowel biopsy revert normal appearance association diet exacerbation meshd004194 see follow dietary therapy
163678	1975	meshd009396 meshc538614 patient meshd013724 contain meshd009396 meshc538614 described rarity renal tissue meshd013724 possible manner development meshd009396 meshc538614 meshd009369 discuss
163679	1975	syndrome meshd005877 meshd007674 meshc536399 meshd009396 new case fetal meshc536399 described meshd009396 occur study observation provide strong evidence interrelationship meshd007674
163680	1975	synovial meshd012509 neck review study 24 case article review clinicopathologic feature biological behavior 24 case meshd013584 study origin cervical prevertebral connective tissue place demonstrate meshd017703 palpable mass anterior later cervical triangle age 24 patient range 10 51 year average 19 year ten patient woman 14 human hoarseness difficulty rest swallow first symptom 8 patient meshd009369 alone range 2 10 cm great property microscopically case show characteristic biphasic cellular normal meshd013584 epithelioid meshd005354 like region vary ratio synovioblastic origin meshd009369 support result histochemical stain procedure 1 case examination electron microscope 21 case review information 12 fail 10 meshd009362 9 active free symptom prompt gross surgical removal require prevent complication recurrent meshd009369 growth metastasis
163681	1975	specific estrogen binding ncbitaxon10116 mammary meshd009369 induced 7 12 dimethylbenz meshc034020 experiment undertaken 7 12 dimethylbenz meshc034020 induced mammary meshd009369 ncbitaxon10116 determine whether meshd010051 differentiate base difference estrogen binding capacity meshd009369 vitro vivo result support report show meshd010051 undergo interaction meshd010051 undergo interaction 17beta 3h estradiol specific estrogen binding component vivo vitro described estrogen direct tissue result demonstrate certain 7 12 dimethylbenz meshc034020 induced meshd009369 remain grow ovariectomy host contain significant amount 17beta 3h estradiol bound cytoplasmic well nuclear component sedimentation property component indistinguishable either ovarian dependent 7 12 dimethylbenz meshc034020 induced meshd009369 ncbitaxon10116 uterus cytoplasmic binding component class meshd009369 exhibit similar specificity estrogen appear absolute correlation estrogen binding capacity meshd009369 growth response ovariectomy
163682	1975	autoantibody antilipoprotein specificity meshd007009 patient meshd009369 serum 151 patient form meshd009369 test antibody like activity lipoprotein 18 serum exhibit activity autologous homologous high density lipoprotein 3 exhibit activity autologous homologous low density lipoprotiens antibody like binding show restriction ncbigene2187 fragment igg reactive function lipoprotein particle show appoprotein quantiation serum lipoprotein indicate thehigh density lipoprotien concentration serum meshd009369 patient significantly low psmaller 0 01 antibody present observation suggest autoimmune mechanism responsible decrease high density lipoprotein serum level patient meshd009369
163683	1975	glycosaminoglycans human meshd008113 method suggest analysis meshd006025 isolated human liver combine meshc005062 electrophoresis enzymatic digestion mucopolysaccharidases major component glycossaminoglycans healthy liver meshd006497 meshd006493 65 approximately equal measure meshd003871 hyalauronic acid 13 5 13 respectively small amount meshd002809 component especially meshd002809 meshd006820 markedly increase meshd056486
163684	1975	blastomogenic activity meshc001418 ncbitaxon10090 blastomogenic activity meshc001418 establish prolong administration c57bl 6 cc57br ncbitaxon10090 meshc017648 test blastomogenic condition preparation aqueous result inject dorsal region double weekly 1 5 mg cause total dose per ncbitaxon10090 42 mg meshc001418 50 mg meshc017648 resorptive type many form blastomogenic activity hydroxphenyllactic acid show induced meshd009369 change histogenesis meshd007938 meshd000236 meshd006528 meshd009369 vascular tissue include benign meshd018198 meshd011230
163685	1975	relative adenylate cyclase activity homogenate plasma membrane fraction meshd008114 5123tc homogenate plasma membrane fraction meshd008114 5123tc ncbitaxon10116 liver study see relation basal activties adenylate cyclase relative responsiveness enzyme meshd005934 meshd012969 meshd004837 meshd000527 insulin basal adenylate cyclase activity meshd006528 found similar liver adenosine 5 triphosphate concentration 3 2 mm substrate affinity km adenosine 5 triphosphate meshd009369 enzyme like liver finding suggest reduce basal cyclic adenosine 3 5 monophosphate level found occur meshd006528 5123tc probably due decrease basal rate formation cyclic base meshd005934 5 6 mum significantly stimulate adenylate cyclase fraction meshd006528 liver responsiveness meshd009369 enzyme hormone well low responsiveness liver homogenate plasma membrane preparation activity enhance 18 fold relation basal activity liver homogenate compare 6 fold increase meshd009369 plasma membrane preparation meshd005934 increase activity 5 3 5 fold liver meshd006528 respectively meshd012969 10mm contrast meshd005934 increase adenylate cyclase activity approximately extent 10 fold liver meshd006528 preparation meshd004837 100 mum enhance liver meshd006528 homogenate activites 3 4 fold meshd006528 plasma membrane activity 2 fold liver plasma membrane activites increase meshd000527 56 6 mum significantly increase adenylate cyclase activites meshd006528 homogenate 1 5 3 fold respectively plasma membrane preparation insulin 0 7 mum significantly change adenylate cyclase activity preparation
163686	1975	increase activity low km cyclic adenosine 3 5 monophosphate phosphodiesterase plasma membrane meshd008114 5123tc total cyclic adenosine 3 5 monophosphate camp phosphodiesterase activity well activity low high enzyme form investigate homogenate 100 000 supernatant plasma membrane fraction ncbitaxon10116 liver meshd008114 5123tc responsiveness meshd006528 liver plasma membrane low phosphodiesterases imidazole 40 mm theophylline 5mm compare camp concentration 1 7 5 mum total camp phosphodiesterase activity meshd009369 homogenate 100 000 supernatant fraction found less one half liver kinetic study homogenate indicate detect largely due significant reduction 53 activity meshd006528 high enzyme contrast low km camp phosphodiesterase activity meshd009369 homogenate plasma membrane fraction significantly 50 high liver especially apparent meshd000242 concentration 0 5 2 mum since concentration range basal physiological level meshd000242 hepatocytes present result suggest reduce level meshd000242 previously observe meshd006528 5123tc primarily due to increase rate meshd000242 metabolism low km meshd000242 phosphodiesterase plasma membrane meshd009369 meshc029899 increase activity low camp phosphodiesterase liver plasma membrane 22 1 mum meshd000242 38 7 5 mum meshd000242 meshd009369 activity enhance 35 50 respectively 1 7 5 mum meshd000242 meshd013806 inhibit plasma membrane phosphodiesterase activity liver 79 53 meshd000242 concentration 1 7 5 mum respectively meshd006528 activity inhibit 82 1 mum meshd000242 62 7 5 mum meshd000242
163687	1975	estrogen ncbigene5617 colony 7 12 dimethylbenz meshc034020 induced meshd009369 hormonal influence dimethylbenz meshc034020 induced meshd009369 growth investigate detail hormone ablation substitution hormone majority meshd009369 regress follow ablation reactivate subsequent administration estrogen 0 1 5 mug ncbigene5617 2 mg increase number meshd009369 stimulate ncbigene5617 administration delayed basal level meshd004958 0 01 mug addition ncbigene5617 require reactivation meshd009369 meshd009256 competitor estrogen receptor site contain growth large component dimethylbenz meshc034020 induced meshd009369 intact animal fail slow growth ncbigene5617 stimulate meshd009369 withdrawal ncbigene5617 meshd009256 rapid regress meshd009369 occur readministration ncbigene5617 fail activate meshd009369 long 28 day result give good support evidence estrogen represent primary role meshd009369 growth interaction ncbigene5617 estrogen meshd009369 site necessary regulatory case related meshd009369 growth
163688	1975	alteration ncbigene25134 activity fetal adult meshd009369 tissue ncbigene25134 activity examine number fetal adult organ well several rodent meshd006528 use enzymatic immunological technique fetal ncbitaxon9986 liver activity first appear low level 20 day postfertilization surface high level birth reach maximal adult liver fast grow meshd006528 activity detect either enzymatic immunological assay detect slow grow meshd006528 well decrease level compare normal adult ncbitaxon10116 liver immunoassay give evidence inactive form enzyme tissue enzymatic activity change rna methyltransferase assay contain simultaneously show inverse relationship ncbigene25134 activity level change rna methyltransferase activity high fetal meshd009369 tissue low normal adult tissue
163689	1975	identification virion vitro l1210 meshd007938 cell line morphological virological immunological technique vitro l1210 cell line contain abundant intracytoplasmic particle numerous type particle small number type particle occasional intracisternal particle intracytoplasmic particle contain spike type fluid surface type particle form budding site type particle developed gradual accululation neucleooid material particle especially type exhibit wide range density cell show strong surface immunofluoresence ncbitaxon10090 mammary meshd009369 virus gross ncbitaxon11786 antigen variable degree cytoplasmic immunoflurescence protein antigen p1 p6 meshd007938 cell culture supernatant purify virus give positive reaction ncbitaxon10090 mammary meshd009369 virus ncbitaxon11786 antiserum immunodiffusion viral particle fail infect c57bl c57bl 6 dba 2f1 hereafter call bd2f1 balb af riiif ncbitaxon10090 howver cell highly tumorigenic bd1f 1 ncbitaxon10090 moderately tumorigenic balb ncbitaxon10090 tumorigenic c57bl af riiif ncbitaxon10090
163690	1975	comparison effect meshd003630 meshd004317 several dna polymerase effect meshd018943 antiboties meshd003630 meshd004317 dna direct activity dna polymerase ncbitaxon11809 ncbitaxon10116 liver high molecular weight specie ncbitaxon562 ncbitaxon1270 determine condition test combine great inhibitory effect viral polymerase cellular polymerase inhibition ncbitaxon11809 dna polymerase meshd003630 competitive respect dna viral dna polymerase conclude inhibition predominatly cause interaction duanomycin primer template dna appreciable reversal meshd003630 induced inhibition polymerase increase mg 2 concentration consistent determination derive competition experiment contrast inhibition ncbitaxon10116 liver ncbitaxon1270 dna polymerase essentially noncompetitive dna bacterial enzyme wer less sensitive inhibition dose virion polymerase strong preferential inhibiton viral dna polymerase discuss relation differential sensitivity normal compare meshd009369 cell observe cell line
163691	1975	heritability phytohemagglutinin responsiveness lymphocyte relationship leukemogenesis upon analysis 59 inbred strain 1 hybrid congenic immune ncbitaxon10090 strain strain distribution normal stimulation perippheral ncbitaxon10090 lymphocyte phytohemagglutinin establish use micromethod family dba ncbitaxon10090 low responder phytohemagglutinin whereas c57 family respond well strain pl exhibit well response response lymphocyte lectin govern two less five major gene unknown linkage direct association 2 histocompatibility complex found although indirect influence locus exclude high meshd007938 strain good responder phytohemagglutinin none low responder group strain exhibit spontaneous meshd007938 correlation response lymphocyte expression type rna genome establish cell suspension animal exhibit clinical sign meshd007938 respond weakly lectin
163692	1975	benzo alpha pyrene effect ncbitaxon10090 epithelial cell culture effect meshd001564 growth culture 5 ncbitaxon10090 epithelial cell strain examine epithelial cell highly sensitive cytotoxic action meshd001564 addition activity benzol meshc030984 metabolize system aryl hydrocarbon hydroxylase low highly iducible carcinogen sensitivity cell strain cytotoxic action benjo pyrene decrease inudcibility hydroxylase decrease strong correlation found meshd064420 level uninduced induced hydroxylase value different cell strain compare experiment suggest thehydroxylase significant determine sensitivity epithelial cell cytotoxic action meshd001564 factor modulate sensitivity
163693	1975	peptidyl proline hydroxylase adult produce neoplastic ncbitaxon10116 tissue sensitive assay system optimally supplement tritiated protocollagen substrate cofactor described suitable determine peptidyl proline hydroxylase pph substance wide spectrum ncbitaxon10116 tissue tissue less 50 percent total activity soluble particulate component activity focus mitochondrial microsomal fraction double pretreatment meshd017830 among normal adult tissue lung high total pph activity 2 4 time liver small bowel low 25 percent liver brain lactate mammary gland activity similar skin 60 percent liver fetal tissue contain 3 8 time pph correspond adult tissue much low component total activity soluble four tissue study detail lung liver kidney brain total pph decline rapidly last day gestation brain reach low adult value term whereas three tissue remain decrease course postnatal development injection cortisol fetal ncbitaxon10116 enhance decline pph lung liver skull experiment suggest normal differentiation decline collagen synthesis initiate fetal glucocorticoid secretion maximal 19th gestational day pph activity appear sensitive indicator neoplastic growth renal mammary muscle meshd056486 pph activity 4 10 time high cognate adult tissue level well differentiate slowgrowing meshd009369 activity well high normal grow immature tissue exception skull lung 19 day old fetus
163694	1975	comparison immunogenicity ncbitaxon10034 cell transform adenovirus herpes simplex virus hamster inoculate adenovirus transform cell modify acetoacetylation concanavalin treatment small number support cell partially whole protect challenge 3 time 10 6 support cell treatment vaccine cell meshd007461 meshd016685 neuraminidase plus meshd016685 produce efficient vaccine herpes simplex virus transform cell treat procedure prevent often level enhance growth homologous support cell enhancement much great female male hamster protective enhance vaccine induce different level cell mediate immunity detect lymphocytotoxicity test positive homologous transform cell nontransformed ncbitaxon10034 cell contrast specific complement dependent cytotoxic antibody active adenovirus transform cell induced protective acetoacetylated vaccine make adenovirus transform cell antibody present nonprotective inoculation appearance herpes simplex meshd014412 delayed treatment immunostimulant meshd007978 preimmunization ncbitaxon11176 grown sv40 transform cell ncbitaxon11176 grown herpes simplex virus transform cell nonspecific treatment able block herpes simplex virus meshd009369 growth protection meshd000257 follow specific cytotoxic antibody
163697	1975	regulation ncbigene25044 ncbigene25634 hyperplastic nodule ncbitaxon10116 liver meshd004052 meshd015073 feed change level ncbigene25044 ncbigene25634 induced dietary stimulation starvation hyperplastic nodule ncbitaxon10116 liver meshd004052 meshd015073 feed study immuno enzyme histochemical method study perform carcinogenesis combine method enzyme histochemistry radioautography ncbigene25044 observe diffusely cytoplasm original hepatocytes periportal zone induced markedly diethynitrosamine feed slightly meshd015073 feed enzyme deficient inducible hyperplastic nodule produce phase later feed period peak level ncbigene25044 inducibility time majority nodule good correlation observe ncbigene25044 ncbigene25634 elevate level response enviornmental stimulation small group hyperplastic nodule deficiency enzyme remain enzyme induction observe great number hyperplastic nodule persistent meshd008661 see meshd004052 carcinogenesis result provide information change biological nature hyperplastic nodule respect metabolic adaptability enzyme level meshd063646
163698	1975	physicochemical characterization novikoff meshd006528 mitochondrial dna mitochondrial dna mtdna isolated ncbitaxon10116 liver novikoff meshd006528 grown solid meshd009369 cell monolayer culture examine form physicochemical technique buoyant density analytical meshc028019 equilibrium gradient thermal denaturation profile reveal significant difference base report among mtdna isolated liver meshd009369 meshd006528 cell sedimentation neurtral alkaline cscl show difference mtdna size meshd009369 meshd006528 cell mtdna slightly small heterogeneous size liver mtdna molecular form duration measure electron microscope base chemical finding neoplastic mitochondrion contain four five time dna per mitochondrion liver electron microscopy show ratio mtdna complex form catenate dimer oligomers much high meshd009369 18 meshd006528 cell 15 liver 4
163699	1975	presence ncbigene3005 degree human tissue histone hidegree found present number human tissue found 50 total 5 meshc576518 soluble histone human breast 35 thyroid 12 18 adrenal 7 parathyroid tissue measure histone hldegree human tissue large compare amount found ncbitaxon10116 liver 8 ncbitaxon9913 thymus 0 hela cell 0 although measure histone hldegree found vary one type tissue another essentially constant normal hyperplastic neoplastic human thyroid tissue
163700	1975	ncbigene24683 estrogen binding transplantable hormone dependent autonomous ncbitaxon10116 mammary meshd002277 hormone dependent subline transplantable ncbitaxon10116 mammary meshd009369 mtw9 control binding site ncbigene24683 estrogen ncbigene24683 binding saturable similar 2 time 10 9 hormone specific destroyed protease contrast autonomous subline derive parent meshd009369 lose 75 ncbigene24683 estrogen binding site although binding affinity hormone unchanged reduction binding site ncbigene24683 estrogen autonomous line result incomplete identification meshd009369 cell direct circulate hormone subsequent release hormone dependent growth characteristic
163718	1975	control phosphorylative activity human liver mitochondrion change respiratory enzyme substance 1 oxidative phosphorylation respiratory enzyme activity measure mitochondrion non involve lobe liver 18 patient massive meshd009369 primarily set one lobe regenerate liver partially hepatectomized ncbitaxon10116 treat meshd002701 2 patient concentration cytochrome change 40 170 pmol mg protein mitochondrion cytochrome concentration 70 pmol mg protein phosphorylative activity per mg mitochondrial protein well high control mitochondrial oxidative phosphorylative activity per unit cytochrome negatively correlate concentration cytochrome patient mitochondrial cytochrome exceed 70 pmol mg protein support partial hepatectomy well give patient mitochondrial cytochrome less 60 pmol mg protein phosphorylative activity low high surgical mortality 3 regenerate liver ncbitaxon10116 treat meshd002701 oxidative phosphorylative activity per unit cytochrome negatively correlate concentration cytochrome 4 suggest increase meshd000255 synthesize activity per unit respiratory assembly basic homeostatic mechanism maintain energy production response increase metabolic load upon hepatic cell
163724	1975	use macrophage electrophoretic mobility test diagnosis meshd016543 source transl macrophage electrophoretic mobility mem test study caspary show ncbigene10216 ncbigene10216 produce specifically sentised blood lymphocyte incubation homologous antigen besides disease cellular immune reaction like multiple meshd009369 show reduction macrophage mobility cell electrophoresis significant inhibition mem test found 30 33 meshd009369 cns meshd005909 meshd001254 meshd008527 meshd004806 meshd009442 meshd008577 meshd005350 show positive result 10 inhibition result meshd009369 meshd010911 meshd003397 differ secondary meshd001932 show great inhibition
163727	1975	vaso active intestinal polypeptide meshd003969 40 year old human meshd003969 refractory watery meshd003967 islet cell meshd010190 islet cell meshd002277 non cell type meshd009362 liver mesenteric lymph node high concentration ncbigene7432 ncbigene7432 demonstrate meshd009369 tissue plasma radioimmunological test surgical removal meshd009369 plasma ncbigene7432 concentration decrease normal immunohistochemical test meshd009369 meshd005767 hormone demonstrate label fluorescence vaso active intestinal polypeptide take polypeptide largely responsible clinical sign described case severe watery meshd003967 cease glucocorticoid administration
163735	1975	change hormone property transplantable multihormonal meshd010911 mtt f4 hypophysectomy host ncbitaxon10116 transplantable ncbitaxon10116 meshd010911 meshc070243 f4 fail grow ncbitaxon10116 hypophysectomize time transplantation grow meshd013974 treat hypophysectomize ncbitaxon10116 latter ncbitaxon10116 meshd009369 stimulate adrenal extent control ncbitaxon10116 meshd009369 stimulate adrenal extent control ncbitaxon10116 meshd009369 cell isolated incubate vitro hypophysectomize meshd013974 treat ncbitaxon10116 free much less corticotrophin incubation medium meshd009369 cell control ncbitaxon10116 free significantly less growth hormone meshd009369 cell intact intact meshd013974 treat thyroidectomized meshd013974 treat ncbitaxon10116 prolactin free isolated meshd009369 cell vitro group study result suggest hypophysectomy meshd013974 treatment host ncbitaxon10116 selectively influence production hormone meshc070243 f4 transplantable ncbitaxon10116 meshd010911
163742	1975	effect fast control meshd005227 synthesis meshd006528 7777 host liver role long range meshd000214 mitochondrial citrate transporter pyruvate dehydrogenase activity effect fast rate meshd005227 synthesis property mitochondrial citrate transporter pyruvate dehydrogenase activity investigate poorly differentiate meshd006528 7777 host liver preparation property citrate transporter meshd006528 similar meshd008107 exception km liver mitochondrial citrate transporter 248 plus minus 20 mu meshd006528 less 75 mu acid insoluble coa substance 180 plus minus 20 pmol mg protein meshd006528 remain essentially unchanged fast state acid insoluble coa level liver give ncbitaxon10116 720 plus minus 80 pmol mg protein increase 1050 plus minus 50 pmol mg protein fast 36 fast rate lipogenesis percent pyruvate dehydrogenase present active form decrease approximately 80 host liver preparation contrast rate lipogenesis meshd006528 slice decrease fast essentially pyruvate dehydrogenase present active form meshd006528 obtain either give fast animal implication interest identification possible regulatory site control lipogenesis discuss relation observation
163780	1975	relationship serum ncbigene174 severity duration meshd002908 patient meshd006525 use radioimmunoassay detect concentration ncbigene174 low 5 ng per ml 38 176 patient meshd006525 compare health volunteer patient meshd002908 involve liver differentiate two group base histologic classification liver biopsy specimen difference degree frequency increase serum ncbigene174 related severity meshd056486 75 patient lesion viral subacute meshd047508 zone meshd009336 bridge adjacent portal 3 central vein 52 increase value 12 level range 500 3300 ng per ml contrast 28 101 patient bridge meshd009336 increase value none level exceed 500 ng per ml patient subacute meshd047508 comparison ncbigene174 concentration duration meshd002908 indicate protein surface peak level serum sgot decline support serial observation 10 patient increase ncbigene174 serum patient severe meshd056486 occur meshd017093 subside due know feature ncbigene174 intrigue reflect increase serum level protein meshd006525 reflect hepatic regeneration parenchymal damage
163793	1975	course occur persistent feline meshd004832 healthy ncbitaxon11768 ncbitaxon11768 infect ncbitaxon9685 meshd003027 environment follow 23 month development disease evidence alteration hemogram incidence disease development ncbitaxon11768 postive ncbitaxon9685 fivefold high incidence ncbitaxon11768 minus ncbitaxon9685 ten case meshd007938 developed 69 infect ncbitaxon9685 whereas one case meshd007938 occur 59 uninfected ncbitaxon9685 incidence development disease meshd007938 30 4 percent ncbitaxon11768 infect ncbitaxon9685 oppose 6 8 per cent uninfected ncbitaxon9685 result immunosuppressive effect ncbitaxon11768 ncbitaxon11768 infect ncbitaxon9685 evidence subclinical meshd000740 mean take cell mass total leukocyte number infect uninfected animal mutant see healthy ncbitaxon11768 infect ncbitaxon9685 decrease mean lymphocyte number difference mean lymphocyte number ncbitaxon11768 infect uninfected animal significant 0 999 level finding suggest incubation period feline meshd007938 prolong natural condition increase susceptibility unrelated meshd003141 exists period increase susceptibility apparently associate meshd000740 meshd000275 total leukocyte number
163824	1975	meshd011732 dependent conformational state glycogen phosphorylase examine interconverting enzyme interaction meshd011732 convertible meshd012694 glycogen phosphorylase investigate use specific interconverting enzyme phosphorylase kinase phosphorylase phosphatase effector meshd005947 meshd019298 protein kinase trypsin phosphorylase kinase phosphorylase phosphatase use native protein small influence apoprotein removal peptide contain critical meshd012694 residue give phosphorylase meshd011732 phosphorylase significant effect enzymic interconversion
163829	1975	hapten sandwich label ii immunospecific attachment cell surface marker suitable scan electron microscopy hapten sandwich procedure use immunospecific label cell surface antigen marker visible scan electron microscopy antihapten antibody use associate hapten modify ncbitaxon12242 bushy stunt virus hemocyanin hapten modify human erythrocyte antihapten antibody bridge use associate hapten virus marker hapten modify antibody mammary meshd009369 virus ncbitaxon10090 mammary meshd009369 cell immunoglobulin receptor ncbitaxon10090 splenic lymphocyte case label highly specific technique possible compare morphological feature cell contain differ cell surface antigen examine system specific antigenic site cell surface distribution relation membrane structure microvilli
163832	1975	cell surface change rous sarcoma virus gene expression synchronize cell investigate whether cell surface change associate growth control malignant transformation associate cell cycle ncbitaxon9031 embryo cell synchronize double meshd013936 block examine cell cycle dependent alteration membrane function measure transport meshd003847 meshd014529 meshd013936 meshd008353 cell surface morphology examine scan electron microscopy ability meshd009369 virus gene expression induce transformation specific change membrane function reach follow determination high rate meshd003847 transport see transform cell low rate meshd003847 meshd014529 transport characteristic density inhibit cell occur normal grow cell cross cell cycle although cell cycle dependent change surface morphology reflect correspond change membrane function tumor virus gene expression change cell membrane function stage cell cycle progression cell cycle
163841	1975	interaction delta 5 androstene 3beta 17beta diol meshd004958 dihydrotestosterone receptor human myometrial mammary meshd009369 tissue specific receptor binding meshd004958 ncbigene106478911 meshd013196 meshd013196 study human myometrial tissue human mammary meshd009369 tissue inhibition binding ncbigene106478911 dht ncbigene106478911 meshd013739 meshd013196 dehydroepiandosterone dhea meshd019314 ncbigene6822 meshd000735 5 androstene 3beta 17beta diol adiol test use meshd003911 surface charcoal interval bound free ncbigene106478911 respectively meshd013196 percent binding inhibition direct source inhibition obtain meshd009256 molar concentration ratio 1 000 ncbigene106478911 binding respectively meshd017373 molar concentration ratio 10 000 meshd013196 binding 15 sample myometrium test receptor found ncbigene106478911 19 sample mammary meshd002277 tissue one show binding activity three sample bind ncbigene106478911 five sample meshd013196 ten sample show binding meshd013256 50 inhibition ncbigene106478911 binding myometrial well meshd009369 tissue require molar concentration ratio 40 adiol 2 000 dhea significant inhibit activity found molar concentration ratio 10 000 ncbigene6822 40 000 see meshd013196 binding meshd015114 active ncbigene106478911 less active substance test meshd015114 therefore one maintain significant inhibit influence molar ratio far beyond physiological range mean adiol interfere receptor level estrogenic stimulation mammary meshd009369 cell
163842	1975	regulation human ncbigene93659 secretion serum meshd003994 malignant trophoblast cell vitro human ncbigene93659 secretion study human malignant trophoblast cell jar line continuous culture radioimmunoassayable ncbigene93659 cell daily culture fluid increase least 3 day 10 newborn ncbitaxon9913 serum 1 mn 6 0 2 dibutyryl cyclic adenosine 3 5 monophosphoric acid dbcamp plus 1 mm theorphylline incubation cell presence serum dbcamp theorphylline result additive stimulation ncbigene93659 secretion 1 day 2 3 day supra additive stimulation observe prevent meshd003609 cell preincubated 2 day absence serum dbcamp plus theorphylline subsequent addition serum result supra additive stimulation ncbigene93659 secretion single day remain presence dbcamp plus meshd013806 necessary stimulation serum finding suggest dbcamp activates slow process require rna synthesis result increase ncbigene93659 secretion serum appear protect ncbigene93659 synthesize system degradation
163843	1975	immunochemical heterogeneity calcitonin plasma calcitonin measure plasma 13 patient medullary throid meshd002277 one patient calcitonin produce islet cell meshd010190 hormone measure simultaneous application two calcitonin antiserum differ specificity calcitonin measurement make gel filtration bio gel p30 fraction plasma sample although two antiserum like sensitivity measurement human calcitonin measure respond differently calcitonin plasma sample one antiserum ld 1 give consistently high estimate hormone concentration plasma patient medullary meshd013964 ld 26 contrast concentration calcitonin islet cell meshd010190 high ld 26 assay multiple gel filtration peak immunoreactive calcitonin activity present thyroidal nonthyroidal calcitonin two different antiserum identify differ immunochemical peak calcitonin activity agiven plasma sample finding demonstrate presence immunochemical heterogeneity plasma calcitonin suggest presence immunological difference thyroidal nonthyroidal calcitonin
35193118	meshd018487 procedure patient meshd002312 case report surgical septal myectomy prefer treatment alternative patient medically intractable meshd002312 lead transaortic septal myectomy widely perform surgical procedure patient subaortic meshd000402 transapical approach provide alternative surgical alternative less common phenotype meshd006984 long segmental septal meshd006984 report describe case procedure perform achieve result meshd006529 procedure use combine transaortic transapical double approach patient diffuse type meshd002312 meshd000783 mid cavity meshd000402
35248534	antibody fc direct conditional antibody dependent cellular meshd064420 meshd009800 microenvironment ph despite exquisite specificity high affinity antibody base meshd009369 therapy treatment position effect occur since meshd009369 associate antigen target present healthy cell low ncbigene5053 ncbigene5053 meshd009369 microenvironment provide opportunity develop conditionally active antibody enhance meshd009369 specificity direct human igg1 fc area enhance ncbigene5053 ncbigene5053 selective binding receptor ncbigene2214 ncbigene2214 subsequent antibody dependent cellular meshd064420 adcc exhibit fc area surface mammalian cell generate site direct library change fc residue fc ncbigene2214 ncbigene2214 interface support interaction positively level meshd006639 residue use competitive stain period cytometric selection strategy isolate fc form exhibit reduce ncbigene2214 ncbigene2214 affinity neutral ph physiological affinity meshd009369 typical ph 6 5 demonstrate antibody compose ncbigene2187 ncbigene2187 arm binding breast cell epithelial marker ncbigene2064 ncbigene2064 lead fc form term acid fc exhibit 2 fold ph selectivity ncbigene2214 ncbigene2214 binding base ratio equilibrium dissociation constant kd 7 4 kd 6 5 due fast dissociation rate ph 7 4 finally vitro adcc assay human ncbigene2214 ncbigene2214 positive natural killer ncbigene2064 ncbigene2064 positive target cell demonstrate similar activity anti ncbigene2064 ncbigene2064 antibody bearing wild type acid fc ph 6 5 almost 20 fold reduce adcc acid fc ph 7 4 base ec50 ratio work show predict mammalian cell show fc technology feasibility ph selective fc activation provide second dimension selective meshd009369 cell target
35509460	recognition competes hydration anion trigger monolayer formation cyanostar supra amphiphiles aqueous interface trigger self assembly surfactant form layer aqueous interface important produce adaptive nanosystems understand selective ion extraction transformation require molecular recognition underlie aim effect modify local environment mode well understand herein investigate role ion binding ion hydration use cyanosurf compose cyanostar macrocycle binding anion either size match mi match either weakly highly hydrate utilize supra amphiphile concept meshd000838 inding change cyanosurf level amphiphilic complex trigger self system monolayers line wa meshd014867 nterface initially cyanosurf form combine surface complete wa meshd014867 olution weakly hydrate size match hexafluorophosphate pf ncbigene200162 ncbigene200162 pe meshc494474 cl meshc494474 anion add macrocycles form distinct monolayer architecture surface pressure isotherm reveal significant reorganization surface active molecule upon anion binding infrared expression absorption spectroscopy show ion limit complex well order interface vibrational sum frequency generation spectroscopy show wa meshd014867 olecules interfacial region highly order response level monolayer cyanosurf complex consistent importance recognition find small mi match ch meshd002712 oes trigger transformation size match ph meshd010710 h2po4 trigger monolayer formation indicate hydration suppress interfacial binding study reveal anion selective recognition hydration control binding change responsive molecular interface selective binding anion transform macrocycles amphiphiles form monolayers surface water depe meshd014867 upon relative role anion hydration anion recognition
35085439	meshd013455 phosphorus oxyacid radical report computational study small study neutral meshc042345 bisulfate dihydro phosphite dihydro phosphate radical hsox h2pox 3 4 predict limited attention various tautomeric structure together pka value calculate gibbs free energy dissociation g4 cam b3lyp level density functional theory energetics microhydration cluster four meshd014867 molecule base specie 8 meshd014867 molecule base specie investigate number microhydrating meshd014867 molecule need cause spontaneous de protonation found correlate acid effectiveness radical accord compute gibbs free reaction activation energy center radical preferentially add double bond meshc013658 meshd008055 model whereas center radical tautomers prefer abstract potential downstream reaction radical biological sensitive discuss
35497620	enhance antivirus activity chimeric ncbitaxon9615 ncbitaxon9615 interferon ricin subunit use nanoparticle expression despite interferon alpha broad spectrum antiviral activity strong antiproliferative activity application severely limited due intrinsic property protein poor stability short serum half life study canine interferon alpha caifnalpha gene combine ricin toxin range rtb form rcaifnalpha rtb encodes 463 amino acid protein contain 15 amino acid encode g4s 3 flexible linker expression prokaryote purification renaturation meshd064420 antiviral activity rcaifnalpha rtb investigate 9615 9615 cell rcaifnalpha rtb exert superior anti meshd054243 ncbitaxon11276 ncbitaxon11276 activity 9615 cell developed nanoparticle expression rcaifnalpha rtb use meshd011094 meshd011094 electrostatic interaction rcaifnalpha rtb pei10000 stable rcaifnalpha rtb various ph temperature level posse enhance antiviral activity finding facilitate research role type ifn antiviral defense response ncbitaxon9615 ncbitaxon9615 despite interferon alpha broad spectrum antiviral activity strong antiproliferative activity application severely limited due intrinsic property protein poor stability short serum half life
35519722	coordinate capillary infiltration anodic oxidation multi functional strategy electrochemical assembly meshd006108 electrochemical scale gr meshd006108 tands promising alternative exist method scalable gr meshd006108 abrication factor order electrochemical process underlie mechanism complex effectively control scale process far completely make despite many effort old work herein first time capillary infiltration anodic oxidation dependence temperature found critical determine electrolyte infiltration anodic oxidation process base achieve line sheet dimension thickness lateral size surface chemistry gr meshd006108 facilely control temperature 5 95 four form gr meshd006108 aterials feature small size porosity wa meshd014867 ispersibility large size selectively fabricate electrolyte system different temperature especially low temperature scale result high yield 99 5 small size gr meshd006108 new find electrochemical method find associate mechanism temperature influence capillary infiltration anodic oxidation change understand electrochemical scale make electrochemistry various technique gr meshd006108 abrication coordinate capillarity infiltration anodic oxidation enable electrochemical assembly various graph meshd006108 rial different temperature
34314500	outcome link eligibility stem cell transplantation trial diffuse meshd045743 abstract objective aim study explore outcome cohort dcssc patient action eligibility criterion stem cell transplantation sct study receive standard immunosuppression method large single center dcssc cohort 636 patient identify use publish sct trial inclusion criterion patient match trial exclusion criterion exclude result 227 eligible patient 214 match inclusion criterion astis autologous stem cell transplantation external scleroderma 82 scot scleroderma cyclophosphamide transplantation 185 upside upfront autologous hematopoietic stem cell transplantation v immunosuppressive medicine early diffuse cutaneou meshd045743 66 exclude base age 65 year low diffuse capacitance lung carbon monoxide dlco pulmonar meshd006976 tini meshd003404 ce 40 ml min mean follow time 12 year 7 among eligible patient 103 45 4 die su meshd003643 al 96 2 year 88 5 year 73 10 year 43 20 year compare sct eligible cohort patient exclude sct trial bad long term selection 97 2 year 77 5 year 52 10 year 15 20 year log rate 0 001 exclude patient significantly bad long term event free selection risk end wa meshd003643 patient high age onset risk ratio hr 1 05 0 001 high esr baseline hr 1 01 0 025 male hr 2 12 0 008 conclusion sct inclusion criterion identify patient poor outcome despite current well practice treatment patient match inclusion criterion sct exclude trial age pulmonary hypertension poor kidney function dl meshd006976 omes
35199148	localpdb python package care protein structure annotation abstract need wealth protein structure collect protein data ba ncbigene55024 ncbigene55024 nabled large scale study function development study require generation customize datasets combine structural data miscellaneous accessory resource provide functional taxonomic annotation unfortunately functionality currently available tool world datasets limited use frequently require laborious survey various data source purpose inconsistency version result address problem developed localpdb various python library management protein structure annotation library feature flexible plugin system enable seamless unification structural data various supplementary resource full version control powerful functionality produce highly customize datasets localpdb use wide range bioinformatic task specific involve large scale protein structural analysis machine study availability implementation localpdb freely available http github com labstructbioinf localpdb support along use case approach http labstructbioinf github io localpdb
35497384	meshd008476 emerge role cardiac magnetic resonance image diagnosis meshd008476
35495276	direct observation meshc004784 trap mof show efficient removal meshd013455 impurity report adsorptive removal follow measure di meshc004784 dm meshc004784 use meshd008670 rganic model mofs cu2 base mofs surface metal site omss cu3 btc 2 hkust 1 btc 1 3 5 benzenetricarboxylate omss cu2 bdc 2 dabco cu jast 1 bdc 1 4 benzenedicarboxylate dabco 1 4 diazabicyclo 2 2 2 octane investigate removal dms compare performance ag zeolite currently widely use industry hkust 1 exhibit well high adsorption capacitance dms adsorbent confirm find measurement adsorption state dms hkust 1 directly reveal single crystal ray diffraction sxrd analysis situ raman spectroscopy addition show dms take hkust 1 level humid condition omss hkust 1 strongly trap dms ev meshc004784 humid condition directly show situ single crystal ray diffraction raman measurement
35496176	prediction human computer interaction intention base eye movement electroencephalograph characteristic order work problem unsmooth inefficient human computer interaction process information age method human computer interaction intention prediction base electroencephalograph eeg signal eye movement signal propose approach different old method researcher predict use data human computer interaction single physiological signal method us eye movement eeg signal clear characterize interaction intention prediction base addition approach test multiple human computer interaction intention take report operator different cognitive state experimental result show method advantage method propose researcher experiment 1 use eye movement signal regression point abscissa position px regression point order position py saccade amplitude ncbigene6296 ncbigene6296 evaluate interaction intention accuracy reach 92 experiment 2 rely pupil diameter pupil size ps determine time determine time meshd004402 eye movement signal achieve high accuracy operator cognitive state eeg signal add cognitive state identify separately combine test eeg parameter ralpha beta eye movement signal pupil diameter regression time accuracy 91 67 experimental combination eye movement eeg signal feature use predict operator interaction intention cognitive state
35516677	mucormycosis follow meshc000657245 meshd007239 epidemic develop pandemic case series tertiary care hospital india world still struggle fight meshc000657245 pandemic epidemic mucormycosis follow meshc000657245 meshd007239 increase india mucormycosis rare life threaten fungal meshd007239 high meshd003643 rate increase due rampant use corticosteroid meshd007154 meshc000657245 uncontrolled blood sugar increase ferritin use industrial meshd010100 use unsterile mask use unsterile meshd014867 humidifier meshd010100 delivery system remains question case series present 5 case meshd009091 follow meshc000657245 meshd007239 patient include patient clinical laboratory radiological data case series review literature
35480622	evaluation urgent retinal practice safety measure physician patient meshc000657245 pandemic purpose ass impact meshc000657245 pandemic urgent retina practice factor influence bond physician patient safety measure method clinical audit urgent meshd007431 present hospital period 15th demonstrate 15th 2020 compare period pandemic resolution 15th december 2019 15th february 2020 additionally two questionnaire assess bond safety measure diffuse medical force sample patient collect data analyze consequently recommendation propose hospital administration specific corrective measure apply outcome apply corrective measure assess audit cycle period 15th june 15th august 2020 result significant decrease number urgent emerge meshd007431 present hospital pandemic 161 versus 302 case similar period pandemic 0 022 pandemic niche significant increase number urgent case 391 versus 161 case pandemic 0 006 increase number complex case resident associate less compliant serve physician bond safety measure conclusion delayed introduction urgent retinal case pandemic highlight importance public awareness urgent condition need prompt medical surgical care attention young physician pandemic important less adherent safety measure due work overload
35479643	vitro sequestration molecular mass spectrum characterize metallophilic meshd002104 broad bacteria sustainable agriculture due industrialization contamination toxic metal stain currently one major care scientist global presence high concentration large metal include meshd002104 environment mainly property human activity highly toxic meshd008670 meshd002104 enrol plant cell transporter usually use uptake essential cation meshd007501 meshd002118 zinc study care appraisement response tolerance show various bacteria change meshd002104 concentration 100 1 000 ppm optical density od isolates measure determine minimal inhibitory concentration mic meshd002104 isolated bacteria identify use 16 rrna gene sequence matrix serve laser desorption ionization time flight mass spectroscopy maldi tof ms among 72 isolates 07 ncbitaxon1408 ncbitaxon1408 ncbitaxon208224 ncbitaxon208224 klebsiella pneumonia ncbitaxon75612 ncbitaxon75612 ncbitaxon303 ncbitaxon303 ncbitaxon46257 ncbitaxon46257 ncbitaxon246432 ncbitaxon246432 isolates efficacy meshd002104 tolerance show sequestration potential change mic meshd011014 observe high 900 ppm tolerance meshd002104 low 600 ppm show ncbitaxon208224 ncbitaxon208224 besides meshd011014 show high 75 2 sequestration potential least 52 4 potential observe ncbitaxon303 ncbitaxon303 meshd002104 broad specie apply contaminate environment detoxification elimination meshd002104 agricultural field
35477744	reliability concurrent validity spinal cord independence measure iii among rehabilitation professional study design track sectional design objective investigate rater reliability spinal cord independence measure scim iii among rehabilitation professional along concurrent validity tool compare standard measure binding wheelchair user wu ambulatory follow individual meshd013119 sci set tertiary rehabilitation center community method 80 two participant sci 39 wu 43 follow individual assess use scim iii point data first 30 participant video show rater reliability assessment 7 rehabilitation professional include harbor occupational therapist physical therapist one novice one receive rater professional participant assess use standard measure control concurrent validity scim iii receive rater result scim iii show excellent intra rater inter rater reliability among rehabilitation professional analyze overall point intraclass correlation coefficient icc 0 90 separately subscale kappa value 0 80 total scim iii wu mobility score follow participant show significant correlation standard measure muscle effectiveness limit stability residue control functional survival walk ability r 0 343 0 779 0 05 conclusion present finding lead clinical benefit confirm use scim iii interchangeably among rehabilitation professional adequately aim finding important community base rehabilitation base healthcare service especially coronaviru ncbitaxon11118 ncbitaxon11118 meshc000657245 hospital layer patient service limited individual sci
35498072	solution phase synthesis meshd009838 use phosphonate method unprotected 5 phosphite monomer recent approach nucleic acid therapeutic increase demand develop efficient method chemical synthesis olig meshd009838 n meshd009838 study report new approach solution phase synthesis odns use phosphonate method unprotected 5 phosphite monomer 5 phosphite monomer synthesize single step unprotected 2 deoxyribonucleosides use 5 selective phosphitylation apply synthetic cycle phosphonate method synthesize four form 5 phosphite monomer optimize condition condensation 3 hydroxy group 5 phosphite monomer phosphonate monoesters result various investigation solution phase synthesis trithymidine diphosphate ttt tetramers contain four form nucleobases achieve accord procedure consist double condensation deprotection purification use simple extraction precipitation new strategy solution phase synthesis oligodeoxyribonucl meshd009838 monomer synthesize single step unprotected 2 deoxyribonucleosides
35476450	immune checkpoint ncbigene102657 ncbigene102657 ncbigene102657 ncbigene102657 determine adipocyte progenitor metabolism meshd009765 development immune checkpoint ncbigene102657 ncbigene102657 ncbigene102657 ncbigene102657 member b7 family study meshd009369 microenvironment immunotherapy potential role metabolism remains largely unknown show ncbigene102657 ncbigene102657 highly show ncbitaxon10090 ncbitaxon10090 human ncbigene230796 ncbigene230796 tissue stabilize state high level adipocyte progenitor cell ncbigene80381 ncbigene80381 rapidly determine upon trigger adipocyte differentiation combine rna sequence metabolic study reveal ncbigene80381 ncbigene80381 cause glycolytic mitochondrial activity adipocyte progenitor release ncbigene80381 ncbigene80381 progenitor result impaired oxidative metabolism program increase meshd008055 aggregation derive adipocytes consistent observation ncbitaxon10090 ncbitaxon10090 knock ncbigene102657 ncbigene102657 develop spontaneous meshd009765 meshd008659 ncbigene230796 ncbigene230796 tissue meshd007249 result reveal unexpected metabolic role ncbigene102657 ncbigene102657 ncbigene230796 ncbigene230796 tissue surface potential new avenue treatment meshd008659 target ncbigene102657 ncbigene102657 pathway immune checkpoint ncbigene102657 ncbigene102657 regulate adipocyte progenitor metabolism protects meshd009765
35508609	dynamic magnetic resonance image muscle contraction facioscapulohumeral meshd009136 quantitative muscle mri meshd014867 t2 fat function increasingly use ass disease involvement meshd009135 image technique assessment dynamic flexible muscle property yet understand clinic exploratory study quantitatively characterize meshd063806 form patient involve facioscapulohumeral meshd009136 ncbigene2489 ncbigene2489 dominant meshd009136 apply dynamic mri synchronize neuromuscular electrical stimulation nmes evaluate quadriceps muscle 34 ambulatory patient 13 healthy control 6 12 month time interval subgroup patient conduct similarly control another subgroup average form decrease time around 57 1 5 year dynamic mri parameter correlate quantitative mri result suggest evaluation muscle contraction nmes mri feasible potentially use explore flexible property monitor muscle involvement ncbigene2489 ncbigene2489 meshd009468
35502422	syphilis transmission exacerbate due meshc000657245 pandemic
35477938	peptidoglycan biosynthesis aim meshd008055 change along enzyme substrate affinity gradient care bacterial cell condition resistance osmotic meshd000079225 peptidoglycan pg show pg biosynthetic enzyme precursor attractive target combat meshd001424 apply native mass spectroscopy clear effect meshd008055 substrate pg membrane enzyme mray murg murj show dimerization mray match binding carrier meshd008055 substrate meshc009621 c55 demonstrate use native ncbitaxon2710868 ncbitaxon2710868 biosynthetic reaction monitoring find passage substrate product control relative binding affinity different membrane enzyme overall provide molecular consider pg membrane enzyme conduct meshd008055 precursor favourable binding event highlight possible opportunity intervention bacterial cell wall enzyme precursor critical target antibiotic development source investigate several biosynthetic enzyme substrate show passage substrate product pathway control relative binding affinity
35494470	calculate absolute binding free energy ncbigene397415 ncbigene397415 dimer explicit result ncbigene397415 ncbigene397415 significant hormone regulation meshd005947 level blood monomer bond form dimer hexamers complex process study binding ncbigene397415 ncbigene397415 dimer first calculate absolute binding free energy lead molecular dynamic method labour method base sham thermodynamic cycle consider limited correction term final calculate binding free energy 298 8 97 1 41 kcal mol 1 conclusion experimental value 7 2 0 8 kcal mol 1 discus important residue residue interaction ncbigene397415 ncbigene397415 monomer include hydrophobic interaction pi pi interaction meshd006859 bond interaction analysis reveal 5 key residue vlab12 tyrb16 pheb24 pheb25 tyrb26 dimerization ncbigene397415 ncbigene397415 perform mm meshc437084 computation wild type dimer mutant study role key residue change binding energy ncbigene397415 ncbigene397415 dimer paper calculate absolute binding free energy insulin dime ncbigene397415 ncbigene397415 eered physician method result 8 97 kcal mol 1 conclusion experimental value 7 2 kcal mol 1 analyze residue residue interaction
35492582	fluctuation external peak demand across quarter basketball game purpose study compare external peak demand pds across quarter basketball 13 elite junior male basketball player monitor use electronic performance track system study interval different time window determine external pd distance player load distance binding four different zone acceleration deceleration combine linear model trial identify difference among quarter auto correlation function carry determine fluctuation across completely game result show significant difference q1 v q2 distance player load base walk distance q1 v q3 distance player load hsr q1 v q4 distance player load base walk hsr q3 v q4 distance player load finding suggest external pd trial base demand distance player load high speed trial decrease across basketball game notable decline occur first quarter quarter still important line non significant difference found quarter several external pd variable jogging trial acceleration deceleration across different time window finding present study reinforce importance consider specific pd variable different function due specific insight provide
35495729	change correlation ncbigene110006 ncbigene110006 microbiota fecal metabolome characteristic experimental meshd010518 rat objective meshd010518 affect progression many disease detailed mechanism remains unclear study promise provide new estimation explore mechanism analyze ncbigene110006 ncbigene110006 microbiota fecal metabolic characteristic experimental meshd010518 ncbitaxon10116 ncbitaxon10116 method total 10 ncbitaxon10116 ncbitaxon10116 randomly part ligature induced experimental meshd010518 ep group healthy control group 4 week experiment stool ncbitaxon10116 ncbitaxon10116 collect sequence 16 ribosomal dna rdna sequence technology fluid chromatography mass spectroscopy lc ms result 16 rdna sequence result show beta diversity gut ncbigene110006 ncbigene110006 robiota significantly different ep control group level dominant genus different compare control group rumi ncbitaxon33038 ncbitaxon33038 ch ncbitaxon562 ncbitaxon562 roseburia significantly enrich ep coprococcus turicibacter lachnospira significantly decrease correlation analysis show roseburia exhibit high correlation genus 3 488 qualitative metabolite 164 metabolite upregulated 362 metabolite downregulated ep enrichment analysis show peri meshd010518 nificantly change 45 positive negative ion metabolic pathway 5 kegg pathway protein digestion absorption novice meshd014443 abolism glycolysis gluconeogenesis niac meshd009525 nico meshd009536 abolism oxidative phosphorylation enrich microbiome metabolome correlation analysis show genus significant difference peri meshd010518 usually significantly correlate metabolite roseburia lachnospira esch ncbitaxon562 ncbitaxon562 ricibacter rumi ncbitaxon33038 ncbitaxon33038 genus change trend run similar correlation certain metabolite addition vita meshd004872 prot meshc028025 significant correlation microorganism conclusion study reveal peri meshd010518 er gut ncbigene110006 ncbigene110006 robiota fecal metabolite correlation analysis microbiota metabolome provide deep understand peri meshd010518 provide management study peri meshd010518 ecting disease
35498708	opportunity challenge predictive approach non cod rna plant
35505069	trend influenza vaccination coverage pregnant woman 10 year analysis french healthcare database pregnant woman high risk severe influenza associate obstetric complication world health system who recommend influenza vaccination pregnant woman since 2012 vaccination coverage remains low global europe due lack proposition health care provider high refusal rate woman primary aim study calculate influenza vaccination coverage ivc population pregnant woman france study development 2009 2018 secondary objective describe vaccinate population find determinant associate vaccination retrospective cohort study base egb french health care database example sample french population contain data health insurance system pregnant woman present medically spontaneously 2009 2018 period include 2009 2018 period 1 2 pregnant woman vaccinate influenza 875 72 207 95 ci 1 14 1 30 ivc slightly increase 2012 who recommendation 0 33 1 79 0 001 remain highly low 4 1 2018 woman young 25 year old low coverage 0 6 whereas woman 35 year old potential obtain influenza vaccine 1 7 or 2 82 95 ci 2 14 3 71 vaccination conduct influence multifetal pregnancy parity socio economically deprive woman less potential vaccinate or 0 81 95 ci 0 67 0 98 woman pre exist medical condition overall high vaccination rate 2 5 or 2 32 95 ci 1 94 2 77 vaccine mainly order family physician 58 influenza vaccination pregnant woman france remains low especially young healthy woman measure information cause towards pregnant woman study knowledge position practice health care professional need undertaken improve coverage
35464058	hormone regulation bone thyroid background hormone organ thyroid number total body release series hormone bone one main target organ thyroid summary review highlight role thyroid hormone meshd013959 bone homeostasis conclusion thyroid hormone play significant role growth development bone instability thyroid hormone impair bone homeostasis
35509580	intracranial fungal ncbitaxon89940 ncbitaxon89940 meshd007239 nonimmunocompromised patient case report review literature background ncbitaxon89940 ncbitaxon89940 dematiaceous fungus rarely infects key neural system cns associate meshd003643 rate 70 despite treatment case description 81 year old female remote history meshc538614 present progressive meshd006261 expressive aphasia 3 day compute tomography image reveal result frontotemporal mass environment vasogenic meshd004487 result frontotemporal craniotomy perform culture reveal ncbitaxon89940 ncbitaxon89940 initial management 4 meshd065819 unsuccessful patient recurrence meshd007239 developed meshd008169 follow addition oral meshd005437 patient show significant improvement complete radiographic result cranial meshd008171 conclusion ncbitaxon89940 ncbitaxon89940 involve cns rare frequently fatal disease surgical management along standard antifungal treatment provide definitive therapy addition meshd005437 4 meshd065819 result positive outcome patient active life independently 1 year original diagnosis rare fungal meshd007239 standard antifungal treatment provide adequate coverage use additional therapy require
35463737	novel dlsnnc sbs base model improve qos healthcare iot application health care system mean enhance one health result one quality life order action social commitment health care must focus produce social benefit support due ever increase demand healthcare sector meshd006261 measure patient data produce need store long duration clinical source risk patient data lose due data center failure minimize include ncbigene161882 ncbigene161882 layer cloud compute architecture effect data produce store cloud order increase service quality present ncbigene161882 ncbigene161882 compute base deep study sigmoid base neural network cluster dlsnnc score base schedule sbs ncbigene161882 ncbigene161882 compute get collect store healthcare data cloud layer use data collect sensor deep study sigmoid base neural network cluster score base schedule approach use determine information ncbigene161882 ncbigene161882 node ncbigene161882 ncbigene161882 layer sensor collect data post ncbigene161882 ncbigene161882 layer cloud compute level responsible monitoring healthcare system exploratory finding show promising result term conclusion conclusion latency network use propose system outperform exist technique term average hold
35501846	randomize trial compare video telecare education v person education dietary regimen compliance patient meshd003924 support clinical telehealth provider background compliance dietary recommendation patient difficult part meshd003920 management nature educational method increase patient awareness question effect method purpose relative method consider therefore study conduct compare effect person education versus video tele education dietary regimen compliance patient t2dm method trial 378 patient ty meshd003924 t2dm random allocate video tele education person education control group patient weight biochemical parameter measure educational program three month recent result mean change patient weight glycemic parameter lipi meshd008055 charge decrease two educational group control group three month period significant difference study variable person video education group post intervention exclude total chol meshd002784 pre post intervention change weight tc hemoglobin a1c trig meshd014280 low density lipoprotein cholesterol significant person group video group none educational program significant impact fast blood suga meshd000073893 density lipoprotein cholesterol high density lipoprotein cholesterol discussion video tele education effective person educational method dietary regimen compliance among patient t2dm three month period therefore recommend use video tele education combination alternative person education method study provide support diabet meshd003920 tor trial registration investigation show iranian register clinical trial center irct20150302021307n4 supplementary information online version control supplementary material available 10 1186 s12902 022 01032 4
35395059	fim fhab adhesins play important role nasal cavity meshd007239 bordetella pertussis transmission novel ncbitaxon10090 ncbitaxon10090 catarrhal meshd007239 model meshd012141 cause bordetella pertussis use quality cause infant meshd003643 pre vaccine era ncbitaxon10090 ncbitaxon10090 model meshd014917 function characterization ncbitaxon520 ncbitaxon520 virulence mechanism biologically relevant meshd003139 level ncbitaxon520 ncbitaxon520 transmission adequately reproduce adult ncbitaxon10090 ncbitaxon10090 due limited proliferation human adjust pathogen ncbitaxon10090 ncbitaxon10090 nasopharyngeal mucosa use meshd007153 c57bl 6j ncbigene17874 ncbigene17874 ko ncbitaxon10090 ncbitaxon10090 achieve ncbitaxon520 ncbitaxon520 proliferation human like high number 108 feasible bacteria per nasal cavity extract rhinosinusitis follow robust shed transmission ncbitaxon520 ncbitaxon520 bacteria adult co family ncbigene17874 ncbigene17874 ko ncbitaxon10090 ncbitaxon10090 experiment comprehensive set ncbitaxon520 ncbitaxon520 mutant reveal pertussis toxin adenylate cyclase toxin hemolysin t3ss effector btea bopc several know virulence factor dispensable nasal cavity meshd007239 ncbitaxon520 ncbitaxon520 transmission immunocompromised ncbigene17874 ncbigene17874 ko ncbitaxon10090 ncbitaxon10090 line mutant lack filamentous hemagglutinin fhab fimbria fim adhesins meshd007239 nasal cavity poorly shed low level fail productively infect co family ncbigene17874 ncbigene17874 ko c57bl 6j ncbitaxon10090 ncbitaxon10090 fhab fimbria appear play critical role ncbitaxon520 ncbitaxon520 transmission report novel ncbitaxon10090 ncbitaxon10090 model ncbitaxon520 ncbitaxon520 induced meshd012220 mode genetic dissection host mechanism involve ncbitaxon520 ncbitaxon520 shed validation key bacterial transmission factor ought target future pertussis vaccine source summary pertussis strictly human meshd012141 fatal young child elderly currently use ncbitaxon10090 ncbitaxon10090 model meshd002543 pulmonary meshd014917 function remarkably well recognition ncbitaxon520 ncbitaxon520 virulence factor development effective pertussis vaccine ncbitaxon520 ncbitaxon520 transmission reproduce adult ncbitaxon10090 ncbitaxon10090 due limited proliferation human pathogen upper airway ncbitaxon10090 ncbitaxon10090 therefore vaccinate nasal cavity meshd007153 ncbigene17874 ncbigene17874 knock ncbitaxon10090 ncbitaxon10090 achieve human like high level meshd007239 provide trigger meshd012220 catarrhal shed bacteria ncbitaxon10090 ncbitaxon10090 nasal cavity efficient transmission meshd007239 onto co family adult animal test set bacterial mutant identify two bacterial adhesins key transmission factor combine ability ncbitaxon10090 ncbitaxon10090 bacterial genetics new base ncbitaxon10090 ncbitaxon10090 model catarrhal phase whoop meshd003371 enable decipher mechanism underlie ncbitaxon520 ncbitaxon520 transmission new host
35501713	tutorial case time series design small area analysis background increase availability data health outcome risk factor collect fine geographical result one main cause surface popularity epidemiological analysis conduct small area level fat data set model important methodological result related model complexity computational demand well linkage harmonisation data collect different geographical level method tutorial illustrate reference case time series design originally propose individual level analysis short term association time change exposure application use data combine small geographical area case time series design plant longitudinal structure time series data self match model case method provide flexible highly adaptable analytical tool methodology well case model complex temporal relationship provide efficient computational system large datasets include longitudinal measurement collect fine geographical level result application case time series small area analysis demonstrate use real data case study ass meshd003643 risk associate high temperature summer 2006 2013 london uk case make use information individual meshd003643 temperature socio economic characteristic collect different geographical level tutorial report various step analysis namely definition case time series structure linkage data well estimation risk association assessment exposure difference code data make available full reproduce result graphical description conclusion reference case time series small area analysis provide valuable analytical tool combine model flexibility computational efficiency increase availability data collect fine geographical scale provide opportunity application address wide range epidemiological question
35427167	waste enable hydrodynamic conductivity tunable bandgap semiconductor electronic transport regimen carrier carrier collision dominant scatter mechanism take new relevance advent ultraclean two dimensional material present combine theoretical experimental study ambipolar hydrodynamic transport bilayer meshd006108 demonstrate conductivity present sum two drude like term describe relative movement electron trap collective movement electron trap plasma predict measure conductivity gapless level neutral bilayer meshd006108 sample temperature main wide range away neutrality electron trap conductivity give single trend set four match parameter provide quantitative accord theory experiment density temperature gap measure work validates recent theory waste enable hydrodynamic conductivity produce link semiconductor physic emerge field viscous electronics theoretical experimental study electron trap friction limited transport bilayer meshd006108 tunable bandgap
35501339	correlate area difference meshd007239 meshd003643 rate first wave meshc000657245 pandemic evidence bayesian model average meshc000657245 pandemic result great discrepancy meshd007239 meshd003643 rate area besides biological epidemiological factor mass social economic criterion influence extent discrepancy appear therefore active consider involve critical socio economic health factor correlate meshd007239 meshd003643 rate outcome pandemic leverage bayesian model average technique area level data investigate whether 28 variable describe various set health socio economic characteristic correlate final number meshd007239 meshd003643 first wave ncbitaxon11118 ncbitaxon11118 pandemic show variable able robustly correlate outcome understand relationship potential correlate explain meshd007239 meshd003643 rate produce meshd007592 distance use distance conclude extent variable able provide credible account meshc000657245 meshd007239 meshd003643 outcome change area heterogeneous feature
35428788	approach infra loss label track corneal endothelial cell vivo follow corneal transplantation initial rapid decline corneal endothelial cell cecs follow surgery direct image post transplantation endothelial cell possible week surgery limited field consider developed label approach use 1 1 dioctadecyl 3 3 3 3 tetramethylindotricarbocyanine iodide dir dye solution enable track label cecs vivo least 1 month initial vitro optimization assessment dye concentration fluorescence cellular meshd064420 cell migration perform diffuse primary cecs subsequently vivo evaluation cellular label assess rabbit lesion heal model finally real time visualization human remains donor tissue cover dir transplantation ncbitaxon9986 ncbitaxon9986 achieve use clinical confocal microscope result reveal detectable fluorescence increase concentration plateau 100 microg ml meshd064420 concentration evaluate dir label cecs detectable vivo 1 month transplantation label donor transplant image trackable vivo acute endothelial rejection 1 rabbit evidence detectable dir positive cell prior chamber dir image provide detailed image transplantation human corneal endothelium enable non invasive observation corneal endothelial morphology follow transplantation
35462638	gratitude family need meshc000657245 pandemic naturalistic observation study investigate influence broad social event meshc000657245 pandemic public expression gratitude spontaneously produce gratitude expression post individual 159 online discussion assembly extract three time period pandemic one year pre pandemic 2 year pre pandemic gratitude expression cod family meshd007153 growth need base maslow theory need result demonstrate high frequency gratitude expression growth opportunity meshc000657245 pandemic compare 2 year prior result demonstrate high frequency gratitude fulfillment meshd007153 need compare growth need year highlight overall salience family finding reveal capacitance broad social event impact public gratitude expression need fulfilment significance policy program mean match need global crisis
35510142	contemporary use outcome radiation chemotherapy unresectable meshd010190 highlight study study 5 624 patient unresectable meshd010190 across real world us practice overall use radiation treatment rt decline among receive rt stereotactic body radiation treatment sbrt increase contemporary risk gast meshd005767 er sbrt decrease background assess radiation treatment rt use complication unresectable panc meshd010190 us compare conventionally fractionate cfrt stereotactic body radiation treatment sbrt inform real world require outcome practice material method analyze 5 624 patient non metastatic unresectable panc meshd010190 522 old patient age 65 diagnose 2006 2013 medicare link data 3 102 young patient age 65 diagnose 2006 2016 marketscan data compare cfrt v sbrt v chemotherapy unique cochran armitage test temporal trend fisher take test relative risk model compare gast ncbigene2770 ncbigene2770 ncbigene2770 ncbigene2770 mplications healthcare payment consumer cost indicator adjust 2015 12 month compare use infer linear regression model log link gamma distribution result rt use decline 55 45 old patient 2006 2013 52 47 young patient 2006 2016 ptrend 0 001 among rt patient sbrt use increase 10 old patient 12 young patient recent year ptrend 0 04 0 001 respectively addition rt associate frequent gi run stri meshd006470 nd fistula delta 3 9 excess event 0 05 temporal model suggest decrease complication time ptrend 0 05 0 05 old young patient among young patient difference gi complication ncbigene2770 ncbigene2770 sbrt v cfrt 0 05 compare among old patient increase complication control sbrt 1 4 fraction v cfrt 0 05 sbrt 5 fraction 0 72 healthcare payment great sbrt compare cfrt chemotherapy us medicare 0 001 employer base insurance 0 001 conclusion real world treatment change toward selectivity rt unresectable pancreatic cancer sbrt uptake meshd010190 complication profile present opportunity optimize current use benefit finding applicable inform future relative cost effectiveness model rt disease
35474647	role pharmacist provide immunization worldwide population lebanese pharmacist make role background vaccination rate remain suboptimal multiple area around world spite evidence immunization one effective intervention prevent morbidity meshd003643 non traditional vaccine provider propose augment immunization coverage pharmacist multiple critical role develop facilitate vaccinate vaccine preventable disease limited data available around expertise practice lebanese pharmacist provide immunization service objective study aim determine predictor associate vaccine administration pharmacist lebanon ass receive practice provide immunization method track sectional study include pharmacist lebanon network base self administer validate questionnaire adjust permission snowball sample technique use collect data electronic self administer questionnaire demonstrate june 2021 network link survey part order pharmacist lebanon show pharmacist collect sample different zone lebanon result total 315 pharmacist include significant positive association found completion immunization training program ora 2 085 95 ci 1 006 4 322 0 048 full time pharmacist ora 2 504 95 ci 1 156 5 426 0 02 1 4 year practice receive ora 3 855 95 ci 1 849 8 039 0 0001 geographical area practice ora 3 201 95 ci 1 242 8 249 0 016 ora 5 373 95 ci 1 859 15 530 0 002 beirut mount lebanon respectively develop public immunization ora 3 012 95 ci 1 281 7 083 0 011 vaccine administration conclusion study highlight need additional immunization training program pharmacist expand ability role immunizers provide intuition policy maker advance legislation associate pharmacy cover education immunization training order enable pharmacist great role direct vaccination
35521587	aggregation induced emission pyridinium pyridinium interaction non covalent intermolecular interaction pyridinium subunit crystal state efficient mean action aggregation induced emission avoid aggregation cause quench non covalent intermolecular pyridinium pyridinium pyridinium arene pi system interaction result aggregation induced emission aie
35498703	untargeted metabolomics shed short diversity major year secondary metabolite malpighiaceae botanical family natural product produce plant one investigate natural source well lead development natural product field level though compound widely explore literature still lack comprehensive investigation aim explore development secondary metabolite produce plant especially classical methodology employ development sensitive hyphenate technique computational tool data process enable study large datasets valuable asset chemosystematic study describe strategy chemotaxonomic investigation use malpighiaceae botanical family model workflow base ms ms untargeted metabolomics spectral research recently report silico classification tool represent recent molecular evolution take family metabolomic analysis reveal different ionization mode extraction protocol significantly impact chemical profile influence chemotaxonomic result spectral research public database reveal several clade genus specific molecular family potential chemical marker taxon silico classification tool able expand malpighiaceae chemical distance year putatively annotate use ancestral case reconstruction find several year metabolite homoplasies non single synapomorphies single sample clade genus workflow combine several approach perform comprehensive evolutionary chemical study require use chemotaxonomic investigation expand chemical knowledge reveal biological insight compound year different biological group
35494688	excellent performance aromatic polyguanamines induced multiple meshd006859 bondable tetraazacalix 2 arene 2 triazine band main range series poly guanamine pg contain tetraazacalix 2 arene 2 triazine mpda2cyc2 successfully prepared solution polycondensation mpda2cyc2 various aromatic diamine aprotic constituent result 51 meshd018021 dditive 5 wt cl 6 hr number average molecular weight mn pg polymer reach 31 500 relatively broad molecular weight distribution mw mn 5 3 show good solubility aprotic constituent result meshc038678 nd meshc013959 concentration 2 mg ml 1 glass conversion temperature tg meshd002244 po meshd011108 ere range 359 392 around 160 high twin po meshd011108 aza calixarene base pg pg coefficient thermal expansion ctes meshd002244 polymer 29 7 48 1 ppm 1 100 cl much low pg sample 59 1 85 1 ppm 1 transparent almost colorless pg take successfully prepared solution range method show maximum tensile effectiveness sigmas modulus egamma extension reveal eb value 151 mpa 6 3 gpa 4 4 respectively pg polymer mpda2cyc2 4 meshc015126 onomers match pg take exhibit sigmas egamma eb value 76 mpa 5 4 gpa 1 6 respectively great thermal mechanical property pg polymer property multiple hy meshd006859 onding interaction mpda2cyc2 residue po meshd011108 ackbone interaction identify infrared spectroscopy measurement broad absorption set around 3000 3400 cm 1 poly guanamine contain tetraazacalix 2 arene 2 triazine band polymer main range meshd011108 utstanding thermal mechanical property develop multiple hydrogen bond
35494547	active stabilization interventional task utilize magnetically control endoscope magnetically trigger robot become increasingly popular medical endoscopy past 10 despite significant improvement autonomy control method progression field medical magnetic endoscope mainly area enhance navigation interventional task biopsy polyp removal time position major procedural component endoscopy small progression practice area due problem adequately control stabilize magnetically trigger endoscope interventional task present paper discus novel model base linear parameter change lpv control approach provide stability interventional direct method linearizes non linear dynamic interaction external actuation system endoscope set equilibrium associate different distance magnetic source endoscope calculate different control equilibrium approach provide global stability overall system validity external disturbance performance lpv approach compare healthy teleoperation control method base relative integral derivative pid control magnetic flexible endoscope mfe program four biopsy different region colon two different system equilibrium perform control need stabilize endoscope presence external disturbance institution biopsy forceps work channel endoscope experiment perform benchtop colon simulator show maximum reduction mean orientation fault endoscope 45 8 lpv control compare pid control
35498408	editorial ovarian stimulation hormone response impact factor affect outcome meshc537182 treatment
35520678	double mode resonance rayleigh scatter colorimetric ncbigene250 ncbigene250 assay base situ meshd001205 induced signal generation meshc016552 nanosheets multimode sense attract broad attention provide one transduction channel improve accuracy sensitivity due structural diversity mno2 nanosheets nanoneedles successively obtain via one step redox reaction different self assembly method mno2 nanosheets posse great optical property include highly strong resonance rayleigh scatter rrs absorbance signal select double mode sense material prompt selectivity al ncbigene250 ncbigene250 al ncbigene250 ncbigene250 towards dephosphorylate meshc011669 aa meshc011669 generate meshd001205 aa ability decompose mno2 nanosheets along optical signal colour change double mode optical al ncbigene250 ncbigene250 ensing program design therefore mno2 nanosheets function colorimetric investigation directly image colour version simple eye moreover detection limit obtain rrs sense mode low 0 17 mu 1 far superior obtain previously report method strategy good feasibility sensitivity show good candidate series al ncbigene250 ncbigene250 xtended sense application multimode sense attract broad attention provide one transduction channel improve accuracy sensitivity
35515049	ultrasensitive specific sensor base dielectric metasurfaces terahertz range ultrasensitive specific sensor base dielectric metasurfaces terahertz range propose design metasurfaces consist multi match shift meshd012825 measure sio2 substrate high fano resonance feature peak high fano resonance form wide expression spectrum set scan weight incident terahertz wave utilize weight scan strategy design metasurface sensor expression spectrum set binding absorption peak meshd014443 meshd012500 deposit different thickness meshd014443 meshd012500 sensor successfully identify detection limit 6 7 mug cm 2 59 35 mug cm 2 respectively performance sensor high sensitivity analyze point show charge candidate recognition fingerprint spectrum terahertz region ultrasensitive specific sensor base dielectric metasurfaces terahertz range propose
35514367	enhance stability meshd012238 meshd015034 catalyst growth zif 8 hydroformylation high meshd000475 hydroformylation ol meshd000475 one important industrial process al meshd000447 roduction therein leach active metal heterogeneous catalyst important result hydroformylation reaction especially high ol meshd000475 produce high al meshd000438 different rh meshd012238 meshd015034 atalysts various zn meshd015034 support investigate base make zno50 support select set rh zno50 zif 8 effect case structure catalyst synthesize growth zif 8 zno50 give template yield zn meshd015032 ource compare rh zno50 catalyst rh zno50 zif 8 catalyst demonstrate well cyclic stability hydroformylation 1 dodecene combine experiment characterization result conclude zif 8 case rh zno50 catalyst effectively prevent leach metal rh reaction solution moreover rh zno50 zif 8 catalyst exhibit good universality high ol meshd000475 work provide useful guideline trap active specie heterogeneous catalyst hydroformylation reaction stability rh meshd012238 meshd015034 alyst hydroformylation 1 dodecene obviously improve property zif 8 case rh meshd012238 meshd015034 alyst effectively prevent leach meta meshd008670
35517931	meshd010165 nanoparticles plant mesoporous carbon efficient common reusable catalyst mild hydrogenation nitroarenes reduction nitroarenes efficient route training aromatic primary meshd000588 reduction generally perform presence heterogeneous tr meshd028561 atalysts instead efficient long slow set addition contain expensive metal case difficult reuse therefore development efficient well accessible reusable pd meshd010165 atalysts obtain rapidly safety non toxic first material apply report two ass synthesis method use first consist impregnation micro mesoporous ca meshd002244 upport pd salt solution follow thermal reduction 300 450 600 second involve direct synthesis base co assembly pyrolysis 600 mix phenolic precursor gl meshd006037 surfactant pd salt obtain composite posse pd meshd010165 anoparticles nps tunable size range 1 2 7 0 nm homogeneously diffuse ca meshd002244 ramework pore wall number successfully use mild environment friendly hydrogenation nitroarenes room temperature h2 meshd003903 1 atm et meshd000431 presence 5 mequiv support pd conclusion optimal characteristic catalyst found second objective study found activity catalyst strongly dependent pd nps size catalyst bearing small pd nps 1 2 nm obtain 300 3 4 nm obtain 450 exhibit excellent activity contain large pd nps 6 4 nm 7 0 nm obtain 600 either indirect direct method active moreover theory reuse catalyst show dependent surface chemistry pd nps small pd nps prone oxidation line surface gradually binding pdo case decrease activity reuse good compromise intrinsic catalytic activity first use theory reuse found catalyst make impregnation follow reduction 450 since hydrogenation perform 2 et meshd000431 level wa meshd014867 catalyst quantitatively find reaction filtration use least 7 time release efficiency well almost pd meshd010165 ree primary aromatic amine obtain since pd meshd010165 eaching low 0 1 present measure compare numerous report literature catalyst report well accessible eco friendly precursor active hydrogenation mild common reaction condition size induced activity reusability mesoporous carbon contain pd nps dem meshd010165 strated herein mild common hydrogenation nitroarenes
35495577	tricuspid ring meshd000686 cardiac involvement detailed analysis three dimensional speckle track echocardiographic magyar track study institution meshd000686 rare condition due extracellular deposit excessive measure protein parenchymal tissue include center present study aim test whether meshd006331 ca associate structural omim614822 ta aim result patient ca compare age gender match healthy control three dimensional speckle track echocardiography 3dste moreover difference ta parameter short range ca al ca transthyretin ca ncbigene7276 ncbigene7276 ca study well material method study contain 27 ca patient mean age 62 7 9 1 year 21 male result compare 20 age gender match healthy offer 59 3 3 8 year 13 male complete two dimensional doppler echocardiography 3dste perform ca patient control result expand conclusion diastolic conclusion systolic ta diameter area perimeter detect ca patient al ca ttr ca subgr ncbigene7276 ncbigene7276 well although ttr ca patie ncbigene7276 ncbigene7276 involve structural ta parameter show tendentiously high compare al ca patient functional parameter ta found reduce ca patient deteriorate al ca patient conclusion expand ta associate functional deterioration ca
34674568	approach community employ research advance health equity condition improve field
35497962	antimicrobial resistance one health approach research review antimicrobial resistance amr conduct part one health approach review publication include antimicrobial resistance one health conduct among global health problem amr one clear illustrate one health approach amr critical global problem affect human environment animal related three component due irresponsible excessive use antimicrobial various sector agriculture livestock human medicine improper management antimicrobial poor control meshd007239 agricultural debris pollutant environment migration mass animal meshd007239 immune bacteria facilitate scatter resistance study aim analyze problem amr health position analyze different player involve one health
35515150	meshc467077 marine sponge metabolite novel inhibitor ncbitaxon2697049 ncbitaxon2697049 key target protein compare suggest meshc000657245 dose design dock molecular dynamic simulation study outbreak ncbitaxon2697049 ncbitaxon2697049 ncbitaxon2697049 ncbitaxon2697049 meshd007239 36 million mass cause around 1 million meshd003643 around world 9 october 2020 escalate outspread virus rapid surface number case require instantaneous development effective dose vaccine currently approve dose vaccine available treat meshd007239 scenario one propitious therapeutic approach meshd001102 explore enzyme inhibitor amidst natural compound utilize computational approach aim obtain product negligible position effect present study inhibitory candidate ilimaquinone marine sponge metabolite assess compare hydroxychloroquine azithromycin favipiravir ivermectin meshc000606551 active binding pocket 9 different critical ncbitaxon2697049 ncbitaxon2697049 target protein spindle receptor binding area rna dependent rna polymerase ncbigene43740578 ncbigene43740578 nsp13 nsp14 nsp15 nsp16 main protease papain like protease employ silico molecular interaction base approach addition molecular dynamic physician simulation ncbitaxon2697049 ncbitaxon2697049 papain like protease ncbigene43740578 ncbigene43740578 meshc467077 complex carry calculate various structural parameter include base mean square fluctuation rmsf base mean square difference rmsd radius gyration rg meshd006859 bond interaction ncbigene43740578 ncbigene43740578 promising dose target due imperative role viral replication additional function slip ubiquitin interferon cause gene 15 ncbigene9636 ncbigene9636 host cell protein short possible inhibition critical ncbitaxon2697049 ncbitaxon2697049 target protein study stress importance study depth meshc467077 action vivo inhibitory potential 49 meshc467077 marine sponge metabolite 9 essential sa ncbitaxon2697049 ncbitaxon2697049 arget protein employ molecular interaction dynamic simulation approach
35509758	rare case esophageal meshd007971 esophageal meshd007971 concern clinical find white speckle mucous membrane surface chip associate meshd000438 ncbitaxon4097 ncbitaxon4097 use chronic acid reflux association meshd002294 meshd009369 report potential malignant transformation warrant endoscopic intervention surveillance guideline exist present case 77 year old female history longstanding meshd004931 require multiple botox injection present meshd015431 meshd003680 acid reflux patient underwent esophagogastroduodenoscopy egd show ncbigene28935 ncbigene28935 mm white plaque center tertiary esophagus histopathology consistent meshd007971 double botox injection treatment ppi h2 blocker finding esophageal meshd007971 line double egd case aim increase awareness rare disease pathology especially set underlie meshd004931 case enhance question maximum anti reflux therapy potential benefit avoid recurrence meshd007971
35365626	ncbigene7398 ncbigene7398 trap lesion source dna replication meshd000079225 genomic instability deubiquitinase ncbigene7398 ncbigene7398 critical regulator genome integrity deubiquitylation meshd005199 dna replication processivity factor ncbigene5111 ncbigene5111 ncbigene5111 ncbigene5111 uniquely follow uv radiation ncbigene7398 ncbigene7398 self inactivates autocleavage enable degradation number upregulates ncbigene5111 ncbigene5111 monoubiquitylation functional role autocleavage event physiological condition remains elusive herein reveal cell harbor autocleavage bad ncbigene7398 ncbigene7398 mutant still able robustly deubiquitylate ncbigene5111 ncbigene5111 receive replication fork stand previous fork result event use extremely result microscopy exist cell single molecule track show flaw related inability ncbigene7398 ncbigene7398 mutant properly reuse site active dna synthesis result replication associate lesion find removal ncbigene7398 ncbigene7398 molecule dna facilitate dna dependent metalloprotease severe counteract meshd064420 cause ncbigene7398 ncbigene7398 trap propose utility ncbigene7398 ncbigene7398 inhibitor meshd009369 therapy base ability cause ncbigene7398 ncbigene7398 trap lesion consequent replication meshd000079225 genomic instability meshd009369 cell similar non covalent dna protein crosslinks cause meshd064420 impose steric hindrance upon protein involve dna transaction source provide mechanistic insight auto cleavage usp1 ncbigene7398 ncbigene7398 biquitinase determine dna replication genome stability significance target usp1 ncbigene7398 ncbigene7398 ivity via protein dna trap canc meshd009369 rapy discuss
35361081	efficacy safety meshd014148 lumbar surgery meta analysis randomize control trial objective meta analysis aim ass meshd014148 meshd014148 effectiveness safety lumbar surgery patient method rehabilitation randomize control trial rcts conduct utilize database medical literature pubmed china science technology journal database cochrane library china subject knowledge base cnki embase compare primary safety endpoint risk ratio rr standard mean difference smd 95 confidence interval cis calculate evaluation quality include study cochrane risk bias criterion use two source result total 49 article enrol include 4 822 patient patient 2 653 administer meshd014148 2 169 control group finding indicate meshd014148 subject significantly low meshd019106 pbl transfusion rate transfusion volume total meshd006473 tbl meshd016063 ibl drainage compare control group besides hemoglobin hb hematocrit hct value high meshd014148 group compare control group safety endpoint meshd014148 significantly reduce dimer level compare control group meshd014148 control group significant version meshd020246 dvt subgroup analysis administer accord administration method meshd014148 performance type intravenous topical meshd014148 combine meta analysis conclusion meta analysis show meshd014148 potential significantly low pbl transfusion rate transfusion volume tbl ibl drainage compare control group besides hb hct value high meshd014148 group compare control group hemostatic potential lumbar spine surgery trustworthy still controversial safety endpoint meshd014148 significantly reduce dimer compare control group significant version dvt meshd014148 control group
35404122	understand specie composition complex fungal community long short study sequence data abstract kingdom fungi highly various morphology ecosystem function yet fungi challenge characterize difficult culture morphologically indistinct overall description analysis lag far ass microbe bacteria classification specie via high throughput sequence increasingly become average pathogen detection microbiome study ncbitaxon1275957 ncbitaxon1275957 monitoring rapid development sequence technology standardize procedure taxonomic assignment long sequence study yet well base focus nanopore sequence technology compare classification community composition analysis line use shotgun amplicon sequence data generate mock community contain 43 fungal specie show regardless sequence methodology use high accuracy specie recognition achieve sequence alignment fungal specific database assessment classification algorithm found apply cutoff question coverage study contig significantly improve classification accuracy community composition analysis major data release generate draft genome assembly three fungal specie nanopore data remove genome database study improve sequence base classification estimation relative sequence abundance use real fungal community data provide practical conduct design metagenomics analysis focus fungi
35454103	meshd003474 meshd000431 effect trembler schwann cell culture meshd000699 common progressive human motor meshd010523 cvclx218 type 1e meshd003711 affect schwann cell due ncbigene18858 ncbigene18858 ncbigene18858 ncbigene18858 mutant modelized trembler ncbitaxon10090 ncbitaxon10090 meshd003474 natural meshd059808 compound obtain ncbitaxon136217 ncbitaxon136217 ncbitaxon136217 ncbitaxon136217 exhibit dose time change antitumor antioxidant neuroprotective property neurotherapeutic action meshd003474 remain elusive propose meshd003474 possible natural treatment subject enhance cellular detoxification mechanism result improvement neurodegenerative trembler phenotype use complicate method obtain enrich schwann cell culture evaluate neurotherapeutic action low dose meshd003474 treatment ncbigene5376 ncbigene5376 expression chaperone ncbigene56717 ncbigene56717 ncbigene2475 ncbigene2475 pathway trembler wild type genotype wild type schwann cell action meshd003474 result strong stimulation chaperone macroautophagy pathway whereas modulation ribophagy show mild effect despite promising neuroprotective effect treatment meshd020271 demonstrate action meshd003474 focus10090 impaired due irreversible impact meshd000431 use common meshd003474 vehicle essential administration result lead expand still limited understand ncbigene5376 ncbigene5376 biology neurobiology reveal intrinsic lability neurodegenerative trembler genotype run involvement physiological mechanism cellular resilience relevant pharmacological treatment neurodegenerative tremble phenotype meshd003474 meshd000431 conclude analysis effect vehicle essential inescapable step comprehensibly ass effect full potential meshd003474 treatment therapeutic purpose
35474822	multifunctional hemostatic pva chitosan sponge load meshd017886 meshd002939 present study report development multifunctional hemostatic sponge control meshd006470 meshd048271 ch meshd011142 meshd011142 select basic polymeric matrix ch pva sponge meshd005990 meshd019343 use crosslinkers ch pva cl enhance mechanical property developed sponge meshd002939 ab add developed sponge conduct antibacterial activity meshd017886 meshd017886 add make sponge suitable bone surgery among developed sponge ch pva cl ha ab sponge demonstrate enhance cell viability mechanical property strong antimicrobial effect ncbitaxon562 ncbitaxon562 ncbitaxon287 ncbitaxon287 ncbitaxon1280 ncbitaxon1280 addition meshd001791 activity addition meshd002939 meshd017886 advance unique synergistic effect antimicrobial activity hemostasis present study present ch pva cl ha ab multifunctional hemostatic sponge suitable bone surgical application
35454475	complicate structure change capillary extrusion binary combine polycarbonate meshd019904 effect pressure shear rate miscibility binary combine contain meshc028237 ncbigene5091 ncbigene5091 low molecular weight poly methyl methacrylate meshd019904 investigate use capillary rheometer pressure shear rate involve miscibility test extrude strand combine provide information cause phase change high pressure pressure induced demixing occur temperature low critical solution temperature lcst combine therefore extrude strand become opaque throughout shear induced combine demixing part strand become opaque distribution shear rate strand case shear induced demixing exterior strand high shear rate region become opaque lcst shear induced combine occur center region strand become opaque
35454027	association concentration essential toxic factor mid trimester amniotic fluid meshd005315 pregnant culture woman present study aim investigate relationship concentration essential toxic factor present amniotic fluid meshd001281 meshd005315 pregnant woman total 156 pregnant white culture woman age 20 43 year test detect high risk meshd002869 first trimester include study meshd001281 sample collect woman number diagnostic treatment procedure mid pregnancy 15 22 week pregnancy concentration various mineral meshd001281 determine inductively match plasma mass spectroscopy genomic hybridization cytogenetic karyotyping perform detect chromosomal aberration fetus genetic analysis reveal chromosomal aberration 19 fetus 12 evaluate woman major abnormality identify trisomy 21 11 trisomy 18 2 meshd057885 2 fetus meshd002869 frequently show low meshd008345 concentration meshd001281 second trimester compare pattern karyotype coincidence observe high meshd007501 level meshd001281 high risk meshd002869 fetus
35455298	meshd000068879 treat refractory livedoid meshd020144 livedoid meshd020144 chronic recurrent meshd012871 seriously affect quality patient life pathogenesis full identify yet retrospective study report successful use anti ncbigene7124 ncbigene7124 factor meshd000068879 three case refractory livedoid meshd020144 report previously addition provide clinical evidence meshd000068879 therapy efficient improve meshd012871 still meshd010146 livedoid meshd020144
35439272	global structural stability role cooperation mutualistic system dynamic system graph provide describe multiple phenomenon different area science specific many complex system ecology study approach paper analize mathematical model study structural stability stationary point feasible present generalization concept determine global structural stability approach match proper mathematical concept structural stability find full description complex dynamic phase distance due nonlinear dynamic fact analyze informational field base global attractor structure completely characterize attractor stable disturbance suppose minimal structurally stable set study point mathematically computationally zone characterize different level biodiversity bipartite graph describe mutualistic antagonistic system population dynamic specific investigate dependence region maximum biodiversity system connectivity matrix reach network topology completely determine validity dynamic complex network study correlation structural stability several graph measure taxonomic study synthetic biological graph present include 10 mutualistic network plant source dispersal 1000 random synthetic network compare role centrality measure modularity conclude importance cooperation effectiveness among node describe area maximum biodiversity indeed show cooperation parameter key role biodiversity measure number secondary support function
35521068	approach safety abortion key human good
35450125	perinatal meshd002389 patient match pregnancy unknown chorionicity gestational age present spontaneous meshd007752 meshd002389 pregnancy rare present unique challenge due potential complication mom baby overall disease state potential treatment alternative purpose case report highlight complexity workup management catatonic patient concurrent acute obstetric care require urgent intervention report case meshd002389 due underlie major meshd000275 patient present spontaneous meshd007752 match pregnancy unknown chorionicity know prenatal care underwent broad workup significant finding lumbar puncture brain mri metabolic lab eeg exclusion several acute underlie condition presumptive diagnosis meshd002389 secondary exacerbation underlie major meshd000275 make change inpatient meshd001523 facility postdelivery treat form meshd008140 meshd000068180 meshd015283 good effect
35521541	flexible technology advanced phase change material summary fluid phase leakage intrinsic meshd009127 meshd010013 longstanding bottleneck phase change material pcms thermal energy store seriously block widespread application advanced energy efficient system emerge flexible composite pcms subject support certain deformation guarantee superior common link integrate device consider reduce march effective solution flexible pcms base thermal regulation technology reallocate thermal energy determine temperature optimal range currently tireless cause give development various flexible pcms base thermal regulation device large step forward take herein systematically abstract assembly technique flexibility evaluation strategy advanced function approach flexible composite pcms exist challenge future position provide term flexible pcms base thermal regulation technique insightful review aim provide depth understand constructive guidance technology advanced flexible multifunctional pcms graphical abstract inorganic material material science material chemistry material synthesis
35325394	analysis common methodological flaw high reference cigarette epidemiology research prevalence vaping know use cigarette vapes vape compose prompt demand reliable evidence base research publish literature subject vaping frequently enhance care characterize good flaw failure bond take scientific methodology narrative review analyze popular vaping study publish medical journal aim evaluate association vaping smoking cessation smoking trigger health outcome analyze 24 include study identify question take address state method mode implementation discussion state conclusion critical assessment line multiplicity flaw study identify model nature flaw many study lack make theory assertion extent theory understand method tailor address question involvement moreover main outcome measure poorly identify data analysis complicate failure control confound factor body literature gateway theory trigger smoking especially unreliable overall result discussion contain numerous unreliable assertion due poor method include data aggregation lack relevance assertion wild many researcher take find causal association support finding meaningful data discussion conclusion study therefore mislead herein identify common flaw study design methodology implementation found publish vaping study present summary recommendation future vaping research aim prompt future researcher bond scientific method produce reliable finding conclusion field vaping research
34089125	well differentiate meshd018208 like morphology ncbigene4193 ncbigene4193 ncbigene1649 ncbigene1649 co amplification well differentiate meshd008080 wdl one common mild tissue meshd012509 adult predilection center age male develop deep ass position retroperitoneum mediastinum spermatic cord occurrence young individual hypopharyngeal region extremely rare event meshd018208 ml like change seldom occur case wdl make diagnosis wdl challenge amplification ncbigene1649 ncbigene1649 gene subset case wdl show associate unique morphology herein present case 36 year old gentleman present difficulty breathing swallow 3 month duration ct scan neck reveal lesion along ass wall hypopharynx measure 3 5 cm histopathologic test reveal meshd009369 compose lobule oval spindle cell large myxoid stroma soft ncbitaxon9031 ncbitaxon9031 wire vasculature vicinity lobule compose variably size adipocytes part dense fibrous septum control atypical hyperchromatic spindle cell immunohistochemistry meshd009369 cell component immunoreactive ncbigene1019 ncbigene1019 negative ncbigene4193 ncbigene4193 fluorescence situ hybridization angle confirm presence ncbigene4193 ncbigene4193 gene amplification evidence ncbigene2521 ncbigene2521 ncbigene1649 ncbigene1649 gene rearrangement ncbigene1649 ncbigene1649 gene expand diagnosis well differentiate meshd008080 large myxoid stroma show first support wdl ml like morphology harbor co amplification ncbigene4193 ncbigene4193 ncbigene1649 ncbigene1649 hypopharynx
35497834	structure octenyl succinic anhydride modify porous meshd013213 improve bioaccessibility meshd019207 emulsion modify porous meshd013213 ps present octenyl succinic anhydride osa moiety synthesize successfully apply emulsion meshd019207 first time pore channel porous meshd013213 provide theory osa modify meshd013213 meshd004952 linkage osa modify ps different level substitution ds confirm meshc000615229 strong state nmr fourier transform infrared spectroscopy ft ir hydrophobic octenyl succinic hydrophilic hydroxyl group osa modify ps show good emulsify capacity use set meshd019207 emulsion bioaccessibility meshd019207 enhance increase ds osa modify starch study pave new mode use porous meshd013213 modification meshd013213 provide attractive alternative obtain emulsion base delivery system bioactive component synthesis application osa modify porous meshd013213
35496521	interface metallization enable radical stable fe2o3 hierarchical anode pseudocapacitors despite significant approach cathode material develop high performance anode remains key challenge future pseudocapacitors fe2o3 consider promising anode candidate due high theoretical capacitance environmental benignity world abundant characteristic low electronic conductivity poor cyclability fe2o3 significantly limit practical application work 3d ni meshd009532 etalized ca meshd002244 anofiber network developed deposit fe2o3 nanosheet anode ni meshd009532 ayer improve electronic conductivity wettability 3d ca meshd002244 ubstrate benefit stability fe2o3 ca meshd002244 nterfaces focus release upon cycle result new design fe2o3 anode composite exhibit high areal capacitance 1 80 cm 2 high mass load 4 2 mg cm 1 radical high capacitance retention 85 1 successive 100 000 cycle outperform report fe2o3 base anode material lead interface metallization method mno2 cathode excellent capacitance retention 108 2 reach 26 000 cycle suggest potentially broad application interface management method advance stability metal oxide material various pseudocapacitive energy store device radical stable fe2o3 anode composite developed nickel match meshd009532 ng interface fe2o3 nanosheets carbon nan meshd002244 substrate high capacitance retention 85 1 100 000 cycle reach high mass load 4 2 mg cm 1
35498598	advanced treatment coal chemical reverse osmosis center three level mabr result reverse osmosis center roc attract significant attention due complex toxic constituent high salt condition work three level membrane air biofilm reactor mabr system make treat wastewater external meshd002244 source effect control condition include aeration pressure reflux ratio temperature meshd016055 time removal performance integrate system evaluate optimize optimal control parameter removal efficiency cod nh4 no3 tn reach 69 36 80 95 54 55 54 36 respectively three dimensional fluorescence analysis indicate meshd006812 largely take raw meshd014867 moreover microbial diversity analysis indicate microbial community structure reactor separately regulate exert different function enhance system performance integrate mabr system exhibit great feasibility potential advanced treatment coal chemical roc mabr system make treat coal chemical reverse osmosis center external carbon meshd002244
35498564	evaluation multiple global analytical indicator batch consistency traditional chinese medicine injection case study paper measure multiple global analytical indicator batch consistency traditional chinese medicine injection tcmis via chemometrics tool comprehensive measure quality consistency different batch injection traditional method fingerprint similarity commonly use tcmi salviae miltiorrhizae ligustrazine hydrochloride injection sli employ model care chemometrics tool primary component analysis pca evaluation multiple global analytical indicator batch consistency include sa meshd002241 ph meshc017616 nd inorganic salt 18 indicator total carry measure quality consistency 13 batch injection provide guizhou baite pharmaceutical co ltd guizhou china compare traditional hplc uv fingerprint similarity evaluation method propose paper comprehensively correctly reflect quality consistency different batch injection paper multi indicator evaluation result show poor batch consistency consistent conclusion result fingerprint similarity evaluation result still show good batch consistency hplc uv fingerprint reflect center uv absorption able reflect center uv absorption light uv absorption lead inappropriate conclusion therefore quality consistency injection effectively measure evaluation multiple global analytical indicator instead hplc uv fingerprint image batch consistency multiple global analytical indicator heat function use present fluctuation critical indicator recognition apply select several indicator yield attention process quality control injection analysis result show na fr meshd005632 fr meshd005632 gl meshd005947 gl meshd005947 meshc069155 meshc069155 da meshc035055 ds meshc035055 sa meshc076944 sa meshc076944 indicator present attention control quality injection predict critical quality control indicator propose method provide source quality control tcmis broad application potential evaluation multiple global analytical indicator batch consistency employ tcmis multivariate statistical tool
35463128	localization center intramuscular nerve dense region suboccipital muscle anatomical study purpose study aim determine body surface puncture position depth center intramuscular nerve dense region suboccipital muscle provide structural guidance accurate botulinum toxin injection treat meshd006261 cause increase suboccipital muscle stress method 20 four remains age 66 5 5 3 year study trend line associate occipital note mastoid process spinous process 7th cervical vertebra consider longitudinal source line horizontal source line respectively sihler stain meshd001466 label ct employ body surface projection point center intramuscular nerve dense region show projection center intramuscular nerve dense region reverse management across cross level show product vertical line point line show pl ncbigene4172 ncbigene4172 part position ncbigene4172 ncbigene4172 pl point line depth center intramuscular nerve dense region identify result sihler stain show one intramuscular nerve dense region suboccipital muscle ncbigene4172 ncbigene4172 center intramuscular nerve dense region site 51 40 45 55 20 55 43 50 pl site 31 38 30 08 16 91 52 94 depth center intramuscular nerve dense region 22 26 22 54 13 14 27 30 part value mean conclusion accurately determine body surface position depth center intramuscular nerve dense region suboccipital muscle service improve botulinum toxin target localization efficiency treat meshd018781
35520928	room temperature synthesize sno2 electron transport layer efficient perovskite solar cell si meshc045358 sno2 widely use electron transport layer etl material perovskite solar cell pscs numerous synthesis method sno2 report require proper thermal treatment sno2 etls herein present simple method synthesize sno2 nanoparticles nps room temperature use bu meshc006848 precipitator proper uv ozone treatment take cl residue excellent sno2 etls obtain thermal anneal high ability conversion efficiency pce prepared pscs 19 22 reverse scan rs 18 79 forward scan fs flexible pscs fabricate high pces 15 27 14 74 rs fs low energy take sno2 etls therefore show great predict flexible pscs commercialization room temperature process sno2 electron transport layer material efficient flexible perovskite solar cell
35464879	association meshd003920 incidence meshd000275 sequence different base gender insight elsa brasil objective investigate association meshd003920 meshd009223 incidence meshd000275 sequence among human woman method data use 12 730 participant 5866 human 6864 woman baseline 2008 2010 follow 1 2012 2014 longitudinal study adult health elsa brasil multicenter cohort brazilian civil servant participant classify meshd003920 use self report clinical information evaluate presence meshd000275 sequence clinical question schedule revise cis association calculate mean logistic regression model raw adjust socio demographic variable result woman classify dm pri meshd009223 baseline 48 great risk 95 confidence interval ci 1 03 2 07 depres meshd000275 de raw model 54 great risk 95 ci 1 06 2 19 final adjust model compare woman classify non dm meshd009223 ignificant association observe human regression model duration dm meshd009223 ncidence depres meshd000275 de 2143 participant 1160 human 983 woman yield significant association conclusion woman classify prior dm great risk meshd009223 depressive sequence su meshd000275 frequent test low bene meshd000275 part multi factorial approach care dm
35515312	efficient catalytic conversion corn stalk meshd014994 meshd005662 sulfonated meshd006108 meshc037556 sulfonated graphene sg prepared employ change corn stalk meshd014994 meshd005662 transmission electron microscopy tem scan electron microscopy sem ray photoelectron spectroscopy xps fourier transform infrared spectroscopy ft ir use characterize sg effect reaction time temperature substrate load catalyst dose result reaction research optimize sg exhibit high catalytic activity conversion meshd014994 corn stalk meshd005662 fairly high furfural yield 96 achieve cl xylose 71 9 furfural yield obtain use 10 7 ratio mass ratio xylose sg 140 48 furfural yield obtain corn stalk base first combine mol xylan glucan corn stalk yield 100 base xylan use substrate load corn stalk catalyst mass ratio 2 14 19 5 hydroxymethylfurfural 5 hmf yield obtain 43 9 yield meshd005662 obtain 20 min addition reusability sg investigate show good stability meshd003681 catalytic conversion corn stalk sulfonated gr meshd006108
35493436	cd47 antibody protects ncbitaxon10090 ncbitaxon10090 meshd004317 induced meshd009202 suppress cardiomyocyte apoptosis cluster differentiation 47 cd47 upregulated ncbitaxon10090 ncbitaxon10090 model meshd004317 meshd004317 induced meshd002311 dcm explore role cd47 development dcm present study cd47 signal block anti cd47 waste antibody acd47 ncbitaxon10090 ncbitaxon10090 meshd004317 induced dcm intraperitoneal administration 10 mg kg meshd004317 week significantly induced development dcm 4 week follow upregulation cd47 expression center tissue co administration meshd004317 7 mg kg acd47 week significantly reduce severity dcm low number disorder low myofibers reduce cardiomyocytes infiltration macrophage center tissue treat ncbitaxon10090 ncbitaxon10090 good effect associate reduce population ncbigene11747 ncbigene11747 7 aad apoptotic cell attenuate formation interstitial meshd005355 release lactate dehydrogenase ldh acd47 treat ncbitaxon10090 ncbitaxon10090 addition co administration acd47 effectively reduce expression ncbigene12028 ncbigene12028 collagen ncbigene16193 ncbigene16193 ncbigene21926 ncbigene21926 ncbitaxon10090 ncbitaxon10090 dcm result support vitro study acd47 pre treatment significantly reduce meshd004317 induced early apoptosis cardiomyocytes suppress expression ncbigene12028 ncbigene12028 adhere ncbigene12362 ncbigene12367 ncbigene12362 ncbigene12367 phosphorylation ncbigene26416 ncbigene26416 therefore acd47 attenuate dcm ncbitaxon10090 ncbitaxon10090 possibly suppress cardiomyocyte early apoptosis ncbigene26416 ncbigene26416 signal cd47 useful therapeutic target treatment dcm
35440044	prospective investigation association ncbitaxon749906 ncbitaxon749906 composition cognitive performance among healthy young adult background emerge evidence ncbitaxon749906 ncbitaxon749906 composition associate several human health outcome include cognitive performance prospective epidemiological study exist none among young adult address gap literature investigate whether ncbitaxon749906 ncbitaxon749906 composition prospectively link fluid intelligence among healthy young adult method 40 individual 65 female 26 year dortmund nutritional anthropometric longitudinally design donald study provide fecal sample ncbitaxon749906 ncbitaxon749906 composition subsequently average 166 day complete cognitive function test use cattell culture average intelligence test revise german version cft 20 assessment ncbitaxon749906 ncbitaxon749906 genus level 16 rrna v3 v4 illumina sequence relative abundance 158 genus sum bacterial community use novel data aim dimension reduction amalgamation fluid intelligence score regression relative abundance bacterial community adjust select covariates result 158 genus mix 12 amalgam bacterial community compose 18 6 10 14 8 10 16 13 12 12 3 11 genus 14 genus bacterial community identify ruminococcaceae coriobacteriaceae dominant community positively associate fluid intelligence score beta 7 8 95 ci 0 62 15 65 0 04 conclusion among healthy young adult abundance gut bacterial community associate fluid intelligence score study propose cognitive performance potentially benefit gut microbiome ncbitaxon749906 ncbitaxon749906 ntion
35453192	evaluate effectiveness outpatient parenteral antimicrobial therapy opat program saudi arabia retrospective study 1 background outpatient parenteral antibiotic therapy opat well base cost effective measure improve efficient use healthcare resource increase layer availability limited publish data available illustrate opat implementation outcome saudi arabia main objective study evaluate effectiveness opat tertiary center saudi arabia 2 method retrospective study clinical graph enrol patient review tertiary care center initial month november 2017 demonstrate 2020 include patient key line enrol opat hospital study period include primary outcome 30 day readmission rate opat patient secondary outcome factor associate opat failure descriptive analysis data use show result 3 result enrol 90 patient 54 60 male mean age 55 16 17 7 year old mean duration antimicrobial treatment 21 9 24 6 day patient complete mean form therapy meshd000077727 frequently use antimicrobial 43 follow meshd014640 11 2 urinary pathway meshd007239 utis common meshd001424 25 patient 26 9 follow meshd010019 16 patient 17 2 lead spectrum beta lactamase ncbitaxon562 ncbitaxon562 high common isolated microorganism 44 9 follow methicillin immune ncbitaxon1280 ncbitaxon1280 mrsa 16 9 readmission hospital therapy require 12 patient 13 3 change hospital care opat care result cost delivery 18 million ncbitaxon2698737 ncbitaxon2698737 overall assessment period avoid total 1984 patient day hospitalization 4 conclusion finding show opat therapy effective minimal hospital readmission therapy complication opat program reduce healthcare cost integrate practice
35519389	molecular dynamic simulation meshc007950 meshc029424 5 5 bitetrazole 1 1 diolate cocrystal energetic ionic salt eis base cocrystal formation cyclot meshc007950 meshc007950 azine 5 5 bitetrazole 1 1 diolate ha bto predict base molecular dynamic simulation ha bto new synthesize environmentally friendly energetic ionic salt meshd012492 good detonation performance low sensitivity calculate powder ray diffraction model intermolecular interaction derive formation new cocrystal structure radial distribution function analysis propose hydrog meshd006859 van der waals vdw effect exist match hmx ha bto hydrog meshd006859 ha bto hmx play large role cohesive energy density mechanical property analyze cohesive energy density hmx ha bto cocrystal large composite hmx ha bto indicate improvement crystal stability cocrystalization compare hmx ha bto hmx ha bto small young modulus mass modulus shear modulus value large value positive cauchy pressure suggest decrea meshd002303 mproved ductibility moreover calculate formation energy 405 79 kj mol 1 298 mean propose cocrystal structure potential synthesize ambient temperature summary predict eis base cocrystal formation safety mechanical property hmx improve via cocrystalization ha bto provide deep insight formation mechanism eis base cocrystal energetic ionic salt base cocrystal form meshd012492 hmx ha bto predict base molecular dynamic simulation
35456341	inulin meshd002794 meshd012838 treatment meshd043183 meshd003248 randomize case control study 1 background ir meshd043183 ibs common disease multiple pathophysiological mechanism involve single treatment patient ibs possible prebiotics good effect ibs patient co meshd003248 2 method randomize track case control study conduct include patient ibs co meshd003248 ibs randomize two group receive specific co meshd003248 iet food supplement contain inulin ch meshd002794 nd si meshd012838 stoptoxin fiterman pharma iasi romania patient evaluate baseline four 8 week use questionnaire ass ib meshd051271 3 result 51 ibs patient include 47 patient conclusion trial 33 woman mean age 52 82 year add stoptoxin diet co meshd003248 rought additional benefit ab meshd015746 everity improve 68 3 diet stoptoxin 0 004 ab bloating severity parameter improve 34 8 0 040 make number per week make consistency accord bristol scale improve statistical significance group 0 05 4 conclusion combination inulin ch meshd002794 nd si meshd012838 ssociated specific co meshd003248 iet obvious clinical good effect ibs patient term bo meshd012778 ab meshd015746 nd bloating
35514699	highly sensitive gas sensor employ biomorphic sno2 multi level tube pore structure bio templated waste flax metal oxide gas sensor porous structure widely use numerous application range health monitoring medical detection safety study report highly sensitive sno2 gas sensor multi level tube pore structure prepared via biomimetic technology use ncbitaxon4006 ncbitaxon4006 waste bio template simple wet chemical process combine subsequent anneal indeed mltps observe improve excellence porous structure gas sense material abundant active site large surface volume ratio overcame lack lack gas diffusion channel porous gas sense material novel multi level tube pore sno2 gas sensor exhibit significantly enhance sense performance radical low response concentration 250 ppb high response 87 9 fast response 9 2 low control temperature 130 good stability meshd005557 base result via reuse agricultural waste study provide new concept low cost synthesis environmentally friendly effective multi level tube pore gas sensor material metal oxide gas sensor widely use numerous application health medical detection safety bio templating waste ncbitaxon4006 ncbitaxon4006 paper report highly sensitive sno2 gas sensor multi level tube pore structure
35457963	effect food linear meshc009495 meshc009495 tumor formation gene expression colon ncbitaxon10090 ncbitaxon10090 ncbitaxon10090 ncbitaxon10090 model meshd015179 meshc009495 tio2 present many different food product food linear e171 currently audit due potential adverse effect include stimulation meshd009369 formation gastrointestinal pathway developed ncbitaxon10090 ncbitaxon10090 ncbitaxon10090 ncbitaxon10090 model study effect e171 meshd015179 crc use cre loxp system produce ncbigene11789 ncbigene11789 gene severe model spontaneously produce meshd015179 pilot study show e171 reveal ncbitaxon10090 ncbitaxon10090 developed meshd015179 follow enhance meshd006965 epithelial cell lymphatic nodule base meshd011127 increase meshd009369 size main study meshd009369 formation study follow exposure 5 mg kgbw day e171 9 week phase meshc009495 exposure show statistically nonsignificant increase number meshd015179 ncbitaxon10090 ncbitaxon10090 well statistically nonsignificant increase average number ncbitaxon10090 ncbitaxon10090 meshd009369 gene expression change colon analyze exposure 1 2 5 mg kgbw day meshc009495 2 7 14 21 day phase 2 completely genome mrna analysis reveal modulation gene pathway involve regulation gene expression cell cycle post translational modification nuclear receptor signal circadian cycle process associate gene involve enhance meshd009369 formation suggest e171 lead meshd009369 formation progression modulation event related meshd007249 activation immune response cell cycle meshd009369 signal
35515012	simulation base assessment trainee performance post meshd006323 resuscitation objective ass trainee performance care patient post ca meshd006323 omplicated st meshd013226 method prospective experimental single center simulation base study trainee range sub intern critical care associate evaluate care post card meshd006323 ient complicate stat meshd013226 itical action point developed modify delphi approach base american center association guideline neurocritical care order emergency neurological life support protocol primary outcome measure critical action point sum score assay validity evidence support finding include serve neurocritical care physician compare performance across four level training result 40 9 participant complete simulation mean sum critical action complete trainee 10 21 49 11 22 trainee express differential diagnosis contain meshd006323 ty two 65 review electrocardiogram know abnormal consult cardiology 40 trainee 81 independently determine first temperature management 20 41 insist need reconsider effect level training critical action checklist sum score novice mean score standard difference sd 4 8 1 8 v average mean score sd 10 4 2 1 v advanced mean score 11 6 3 0 v good mean score sd 14 7 2 2 conclusion high fidelity model base simulation control predict assessment tool performance post cardiac contain meshd006323
35455649	epigenetics precision nutrition precision nutrition emerge area nutrition research primary focus individual variability response dietary lifestyle factor mainly determine individual intrinsic version genome epigenome ncbitaxon749906 ncbitaxon749906 current research precision nutrition heavily focus genome ncbitaxon749906 ncbitaxon749906 epigenome dna methylation non cod rnas histone modification largely neglect epigenome number interface human genome environmental stressor include diet lifestyle increase evidence suggest epigenetic modification especially dna methylation determine individual variability metabolic health response dietary lifestyle factor therefore control great predict reveal novel marker precision nutrition potential target precision intervention review sum recent study dna methylation meshd009765 meshd003920 meshd002318 stress set relative dna methylation nutrition diet lifestyle intervention briefly review epigenetic event non cod rnas relative human health nutrition discuss potential role epigenetics precision nutrition research
35504139	effect area meshc091692 transducer efficiency ultrasonic atomization aim resonance vibration highlight ln base device produce peak meshd014867 molecule size range 3 2 4 2 microm large transducer area increase atomization volume decrease efficiency optimal ln size efficient atomization area found 8 mm 10 mm fem result resistance analysis suggest mode combine reduce atomization recent year individual control one personal environment make increase attention due produce involvement health care wearable device especially useful controllability regardless position humidity one inevitable factor personal environment preventive infec meshd003141 hough atomization device commonly use method humidity control present wearable humidity control device vibration lithi meshc091692 device thickness mode promising piezoelectric method miniaturization atomization device humidity control miniaturize atomization device transducer size need small much decrease atomization efficiency effect device area atomization efficiency ln size suitable mount wearable device study conduct atomization presentation ln device different size evaluate molecule size atomization efficiency reveal relationship vibration conduct atomization efficiency resonance vibration mhz frequency set evaluate finite factor method resistance analyzer result show peak size water meshd014867 icles atomize device range 3 2 4 2 microm small molecule produce typical piezoelectric ceramic moreover well ln size efficient atomization found 8 mm 10 mm among 5 ln device size use experiment relationship vibration conduct atomization efficiency size transducer suggest affect vibration mode obtain result suggest ln device suitable small wearable nebulizer device
35448474	characterization constituent potential anti inflammatory activity chinese ncbitaxon638626 ncbitaxon638626 specie uhplc hrms base metabolite profile study center detect potentially anti inflammatory active constituent ethanolic extract chinese ncbitaxon638626 ncbitaxon638626 specie take uhplc hrms base metabolite profile approach extract 8 different ncbitaxon638626 ncbitaxon638626 specie subject uhplc hrms analysis pharmacological test three different cellular meshd007249 related assay compound exhibit high correlation orthogonal projection latent structure discriminant analysis opls da pharmacological ms data function potentially activity related candidate candidate 65 tentatively unambiguously annotate 7 hydroxy 5 3 4 5 tetramethoxyflavone three meshd005419 well three c32 one c34 acetylate polyhydroxy fat acid isolated ncbitaxon638626 ncbitaxon638626 leaf first time structure full part clear potentially active candidate compound 15 subsequently subject pharmacological test activity experimentally control part stress relevance ncbitaxon638626 ncbitaxon638626 specie source anti inflammatory active constituent compound impaired cell viability overall approach found useful narrow number potentially bioactive constituent complex extract investigate future application complicate concept extract prefractionation combine bio chemometrics service enhance reliability candidate selection
35454494	3d publish double helical biodegradable meshd007501 suture anchor rabbit rotator cuff charge model suture anchor extensively use rotator cuff charge surgery progression three dimensional publish technology biodegradable meshd008670 developed orthopedic application study follow three dimensional publish biodegradable meshd007501 suture anchor double helical thread commercialize non release ass type meshd014025 suture anchor point lead experimental control group respectively vitro study show meshd007501 meshd014025 suture anchor exhibit similar ultimate failure load 20 pound per cubic base meshd011140 foam block rabbit bone still concentration test corrosion rate meshd007501 suture anchor 0 049 0 002 mm year vivo study perform new zealand white ncbitaxon9986 ncbitaxon9986 sas employ reattach meshd052256 vivo ultimate failure load meshd007501 suture anchor superior meshd014025 suture anchor 6 week micro compute tomography show bone volume fraction bone surface density meshd007501 suture anchor group 2 6 week surgery superior histology confirm increase bone volume around anchor attributable mineralize osteocyte three dimensional publish meshd007501 suture anchor outperform currently use meshd014025 suture anchor
35455173	intrinsic dimension estimation base feature selection multinomial logistic regression classification bearing flaw use compressively sample vibration signal failure range bearing lead major failure rotate machine recent vibration base range bearing flaw diagnosis technique focus obtain useful flaw feature huge aggregation raw data many feature reduce classification accuracy increase computation time paper aim effective feature selection technique base intrinsic dimension estimation compressively sample vibration signal first compressive sample ncbigene1431 ncbigene1431 use obtain compress measurement collect raw vibration signal global dimension computer geodesic minimal couple tree gmst employ compute minimal number feature need present efficiently compressively sample signal finally feature selection process combine stochastic proximity plant spe neighbourhood component analysis nca use select few feature bearing flaw diagnosis regression analysis base predictive model technique multinomial logistic regression mlr classifier select feature assess two case study range bearing vibration signal different work load experimental result demonstrate propose method successfully select few feature mlr base aim model achieve high classification accuracy significantly reduce computation time compare publish research
35089544	survey labour epidural practice obstetric anesthesia family program combine state purpose labour epidural analgesia lea develop field various neuraxial technique dose regimen available advanced obstetric anesthesia provider provide significant practice variability get research consensus optimal care assay question family training practice lea method conduct electronic survey institution american council graduate medical education accredit obstetric anesthesiology family program study frequency epidural trigger technique include combine spinal epidural ncbigene1433 ncbigene1433 dural puncture epidural epidural bolus care technique measure use continuous epidural extract program intermittent bolus pieb patient control epidural analgesia pcea result 40 institution survey receive 32 response 80 response rate 20 8 40 70 include analysis plurality institution 12 28 43 prefer ncbigene1433 ncbigene1433 among use ncbigene1433 ncbigene1433 23 27 85 include intrathecal opioids majority institution use protocol pieb 55 almost 92 use pcea participant 88 report use reduce concentration care extract 0 1 meshd002045 meshd000077212 less conclusion despite significant variability lea practice make model emerge survey include preference opioid contain ncbigene1433 ncbigene1433 care pieb pcea reduce epidural solution supplementary information online version control supplementary material available 10 1007 s12630 022 02192 6
35253772	decrease ncbigene66734 ncbigene66734 associate phagocytosis meshd006816 striatal astrocyte background recent year function astrocyte change conventional supportive role include active role change synapsis engulfment cellular debris recent study implicate astrocyte protective pathogenic role impact hu meshd006816 hd meshd006816 progression objective end study determine phagocytosis cellular debris compromise hd meshd006816 iatal astrocyte method primary adult astrocyte derive two hd meshd006816 ncbitaxon10090 ncbitaxon10090 el fast progression r6 2 dense progression q175 use laser nanosurgery single astrocyte lysed astrocyte network phagocytic response astrocyte observe phase line fluorescence microscopy gfp lc3 transiently transfected cell result astrocyte phagocytosis significantly decrease primary astrocyte consistent progression hd meshd006816 r6 2 q175 mous ncbitaxon10090 ncbitaxon10090 el determine number astrocyte respond via phagocytosis average number vesicle form per cell gfp lc3 ncbigene66734 ncbigene66734 found increasingly set phagocytic vesicle 20 min image period hd meshd006816 ncbitaxon10090 ncbitaxon10090 ggesting involvement lc3 ncbigene66734 ncbigene66734 astrocyte phagocytosis conclusion demonstrate progressive decrease lc3 ncbigene66734 ncbigene66734 ociated phagocytosis hd meshd006816 ncbitaxon10090 ncbitaxon10090 iatal astrocyte
35454502	electrochemical self assemble gold nanoparticle sers substrate match diazotization sensitive detection meshd009573 accurate conclusion meshd009573 food sample great significance control mass health safety herein rapid low cost detection method developed highly sensitive selective detection meshd009573 base surface enhance raman scatter sers sensor combine electrochemical technology diazo reaction work gold nanoparticle aunp meshc109984 meshc109984 chip superior sers substrate obtain electrochemical self assemble aunps ito advantage good uniformity high reproducibility long time stability meshd001391 generate diazotization match reaction meshd009573 meshc064316 meshc064316 meshc008588 meshc008588 acid condition assemble surface aunp ito detection meshd009573 make use portable raman spectrometer base significant sers enhancement meshd001391 assemble aunp ito chip many experimental condition optimize time electrochemical self assembly concentration haucl4 optimal condition design sers sensor detect nitride large linear range 1 0 10 6 1 0 10 3 mol 1 low limit detection 0 33 mumol 1 additionally meshd009573 real sample analyze recovery 95 1 109 7 therefore propose sers method show potential application detection meshd009573 complex food sample
35457702	bibliometric density visualisation function analysis domestic violence australia research yield 1984 2019 domestic violence highly dominant australia good complex impact study aim study research yield domestic violence australia period 1984 2019 article relevant domestic violence australia match condition inclusion criterion find use scopus database bibliometric analysis yield conduct study trend publication trend increase publication associate domestic violence australia time identify majority publish institution site densely populate great city significant diversity found subject subject highly reference article reflect far reach impact domestic violence increase social attention domestic violence time reflect increase publication future research benefit study trend report domestic violence study effectiveness intervention perpetrator victim
35457070	retention benefit age app ncbigene19164 ncbigene19164 ncbitaxon10090 ncbitaxon10090 long term intranasal treatment low dose meshd013759 meshd013759 use promising treatment approach meshd009422 highly psychoactive effect largely warn many scientist follow conduct intranasal treatment use low dose meshd013759 12 month old app ncbigene19164 ncbigene19164 ncbitaxon10090 ncbitaxon10090 daily 3 month overcome potential psychoactive response induced systemic delivery result demonstrate meshd013759 nasal treatment 0 002 0 02 mg kg significantly dense meshd003072 compare vehicle treat ncbitaxon10090 ncbitaxon10090 ncbitaxon10090 ncbitaxon10090 control group enzyme link immunosorbent assay show abeta1 40 1 42 peptide decrease meshd013759 treat group western stain data indicate long term low dose meshd013759 intranasal administration advance tau level reduction mitochondrial function marker redistribution blood biochemical parameter data demonstrate insignificant change cytokine immunoglobulin immune cell profile intranasal meshd013759 treatment intranasal delivery non invasive convenient method rapidly target therapeutic brain minimize systemic exposure avoid unwanted adverse effect study provide new insight role low dose meshd013759 intranasal treatment pharmacological strategy counteract change meshd000544 related cognitive performance
35454267	influence conditioning expansion characteristic apparent metabolizable energy standardize ileal amino acid digestibility full fat ncbitaxon3847 ncbitaxon3847 broiler simple summary full fat ncbitaxon3847 ncbitaxon3847 ffsb valuable source energy protein poultry obtain cleft raw ncbitaxon3847 ncbitaxon3847 make meshd009821 extraction due presence trypsin inhibitor lectin raw ffsb use poultry diet anti nutritional factor heat labile proper hydrothermal process inactivate factor eliminate adverse effect food use bird performance aim present study investigate influence conditioning expansion characteristic apparent metabolizable energy standardize ileal digestibility meshd013398 amino acid aa ffsb broiler base result long term conditioning 100 6 min follow expansion 18 kwh specific energy input increase metabolizable energy meshd013398 aa ffsb increase conditioning time 6 min expansion specific energy input 18 kwh provide advantage metabolizable energy aa digestibility ffsb abstract study investigate influence short term long term conditioning expansion meshd009584 set apparent metabolizable energy amen standardize ileal digestibility meshd013398 amino acid aa full fat ncbitaxon3847 ncbitaxon3847 ffsb broiler batch raw ncbitaxon3847 ncbitaxon3847 use fabrication 10 ffsb product t0 t9 apply various combination conditioning expansion amen meshd013398 aa ffsb determine difference direct method respectively heat treatment increase 0 001 amen compare raw ffsb sample subject long term conditioning 100 6 min expansion 18 kwh t5 support 3 88 meshd009207 kg high amen raw ffsb raw ffsb poor 0 05 aa digestibility among heat treat sample high 0 05 meshd013398 aa show t5 result demonstrate long term conditioning ffsb 100 6 min prior expansion 18 kwh specific energy input enhance metabolizable energy meshd013398 aa increase conditioning time 6 9 min expansion specific energy input 18 28 kwh yield additional benefit energy use aa digestibility ffsb
35455561	evaluation ncbigene2260 ncbigene2260 ncbigene2263 ncbigene2263 ncbigene2308 ncbigene2308 orofacial cleft tissue although meshd002971 meshd002972 cl one common meshd000013 global morphopathogenesis meshc566419 still unclear many candidate gene propose play causal role confirm result many still assess take report significance ncbigene2260 ncbigene2260 ncbigene2263 ncbigene2263 ncbigene2308 ncbigene2308 embryogenesis aim work detect compare three candidate gene cleft involve ncbigene23049 ncbigene23049 palatine tissue 10 mild tissue sample take cheiloplasty veloplasty signal candidate gene image use chromogenic situ hybridization analyze use semi quantitative method statistically important difference distribution ncbigene2260 ncbigene2260 ncbigene2263 ncbigene2263 ncbigene2308 ncbigene2308 neither patient ncbigene23049 ncbigene23049 vomer mucosa control group observe statistically significant strong strong correlation found gene ncbigene23049 ncbigene23049 palatine tissue expression ncbigene2260 ncbigene2260 ncbigene2263 ncbigene2263 ncbigene2308 ncbigene2308 cleft involve ncbigene23049 ncbigene23049 palatine tissue appear highly individual numerous intercorrelations gene exclude role possible complex morphopathogenesis orofacial cleft
35457280	bone marrow niche hematopoietic stem progenitor cell mammalian hematopoietic system remarkably efficient match organism critical need yet highly sensitive fine determine much organismal control meshc536227 follow regulation hematopoietic stem cell hscs specific microenvironments predict niche bone marrow movement hscs reside experimental study conclusion two 10 use advanced advanced technique provide important data identity niche cell control hscs function mechanism underlie niche hsc interaction review discus various expression system function hsc cell niche bone marrow specific review form movement niche various cell type compose niche niche differentiate cell metabolism hscs relative niche niche age leukemic transformation niche current state hsc niche model vitro
35456702	evaluation ctb slip target meshd015179 lung metastasis meshd015179 common clinic accurate target diagnosis therapy purpose meshd009362 remains challenge herein ncbigene236899 ncbigene236899 ncbigene236899 ncbigene236899 protein chemically conjugate surface pegylated liposome ctb slip human derive meshd015179 cell line cvcl0291 cvcl0320 demonstrate high binding affinity cellular uptake ncbigene9468 ncbigene9468 slip vivo ctb slip exhibit advance target capacity lung metastasis meshd015179 model ncbitaxon10090 ncbitaxon10090 compare pegylated liposome slip ncbigene236899 ncbigene236899 modification ncbigene236899 ncbigene236899 conjugation induced ignorable effect interaction liposome plasma protein significantly enhance uptake liposome numerous blood cell splenic cell lead relatively rapid blood clearance balb ncbitaxon10090 ncbitaxon10090 level though double injection ctb slip induced product anti ncbigene236899 ncbigene236899 antibody result suggest ncbigene236899 ncbigene236899 slip promising nanocarriers diagnosis meshd015179
35458663	meshd003998 monoesters beta delta lactam synthesis 2 methoxy 2 oxoethyl phenylsulfonyl glycine monomethyl ester various meshd003998 involve reaction imines advance meshc031800 advance temperature instead initially require delta lactam product castagnoli cushman type reaction medicinally important 3 amino 2 azetidinones obtain result cyclization involve methylene group adjacent acid moiety line replace meshd000438 residue hexafluoroisopropyl substrate make another methylene group adjacent meshd004952 moiety reactive provide desire delta lactam castagnoli cushman mode
35492406	physiological acclimation ncbigene131096 ncbigene131096 population restoration missouri ozarks usa abstract conservation translocation intentional movement animal fix population increase past 30 year stem reverse specie decline release many challenge translocate animal case consider restoration program successful understand long take translocate animal acclimate challenge new landscape critical component post release population management physiological measure hormone response increasingly use ass animal response acclimation disturbance include translocation determine physiological acclimation period ncbigene131096 ncbigene131096 ncbitaxon9861 ncbitaxon9861 translocate missouri ozarks usa part restoration cause 2011 2013 translocate 108 gps radio arrest ncbigene131096 ncbigene131096 kentucky usa missouri usa collect fecal sample glucocorticoid metabolite extraction use indicator physiological acclimation model response population wide fecal glucocorticoid metabolite fgcms across initial 9 year restoration response day follow release additional site specific covariates presence ncbitaxon9874 ncbitaxon9874 ncbitaxon9874 ncbitaxon9874 run monthly precipitation level positively negatively associate fgcm level respectively concurrent influence site specific condition release landscape fgcm level decline follow release identify breakpoint fgcm decline 42 day follow translocation release suggest ncbigene131096 ncbigene131096 acclimate physiologically relatively rapidly compare specie fast physiological acclimation missouri ncbigene131096 ncbigene131096 propose effective use temporary post release management cause determine rapidly animal acclimate follow translocation provide researcher tailor post release management design specie need maximize success future translocation cause minimize cost
35351860	bone marrow mesenchymal stem cell derive exosomal microrna 381 3p facilitate meshd061205 target nfat5 meshd061205 vc significant complication meshd051436 ckd cellular apoptosis one intricate mechanism vc bone marrow mesenchymal stem cell derive exosome bmsc exo facilitate vc mechanism remains unclear investigate mechanism bmsc exo use high meshd010710 cause human aortic still muscle cell ha vsmcs 5 6 subtotal nephrectomy ncbigene310 ncbigene310 ncbitaxon10116 ncbitaxon10116 model demonstrate effect bmsc exo inhibition cellular apoptosis meshd002114 part calculate exosomal microrna 381 3p mir 381 3p vivo vitro confirm mir 381 3p suppress ncbigene307820 ncbigene307820 ncbigene307820 ncbigene307820 expression directly binding 3 untranslated region additionally found severe meshd002114 artery dialysis patient associate decrease mir 381 3p increase ncbigene10725 ncbigene10725 expression level collectively finding show bmsc exo play anti meshd002114 anti apoptosis role ckd present introduce mir 381 3p directly target ncbigene10725 ncbigene10725 mrna lead well understand mechanism meshd012080
35498133	association combine effect ncbigene3479 ncbigene3479 gene polymorphism negative life event major meshd000275 among chinese population context oxidative meshd000079225 background oxidative focus increase number meshd001523 include major meshd000275 meshd003865 meshd003865 show related ncbigene3479 ncbigene3479 ncbigene3479 ncbigene3479 well negative life event explore interaction ncbigene3479 ncbigene3479 polymorphism negative life event risk meshd003865 need aim study analyze single combine effect ncbigene3479 ncbigene3479 polymorphism snptmvar rs972936 snpvariantgroup 4 snpcorrespondinggene 3479 snprs 972936 snpcorrespondingspecies 9606 snptmvar rs978458 snpvariantgroup 1 snpcorrespondinggene 3479 snprs 978458 snpcorrespondingspecies 9606 negative life event meshd003865 among chinese population method 420 meshd003865 patient accord dsm 420 age gender match control subject enrol case control study negative life event assess use standard rate scale ncbigene3479 ncbigene3479 snptmvar rs972936 snpvariantgroup 4 snpcorrespondinggene 3479 snprs 972936 snpcorrespondingspecies 9606 snptmvar rs978458 snpvariantgroup 1 snpcorrespondinggene 3479 snprs 978458 snpcorrespondingspecies 9606 identify sequence chi square chi2 test perform explore association negative life event ncbigene3479 ncbigene3479 polymorphism meshd003865 result result found negative life event associate risk meshd003865 0 001 or 3 28 95 ci 2 19 4 85 genotype ncbigene3479 ncbigene3479 associate risk meshd003865 0 001 carry ncbigene3479 ncbigene3479 snptmvar rs972936 snpvariantgroup 4 snpcorrespondinggene 3479 snprs 972936 snpcorrespondingspecies 9606 allele or 1 53 95 ci 1 26 1 85 snptmvar rs978458 snpvariantgroup 1 snpcorrespondinggene 3479 snprs 978458 snpcorrespondingspecies 9606 allele or 1 92 95 ci 1 58 2 34 high risk meshd003865 combine effect ncbigene3479 ncbigene3479 snptmvar rs978458 snpvariantgroup 1 snpcorrespondinggene 3479 snprs 978458 snpcorrespondingspecies 9606 negative life event associate risk meshd003865 0 05 or 2 94 95 ci 1 23 7 03 ncbigene3479 ncbigene3479 snptmvar rs972936 snpvariantgroup 4 snpcorrespondinggene 3479 snprs 972936 snpcorrespondingspecies 9606 associate 0 05 conclusion base oxidative focus theory confirm carry ncbigene3479 ncbigene3479 snptmvar rs972936 snpvariantgroup 4 snpcorrespondinggene 3479 snprs 972936 snpcorrespondingspecies 9606 allele snptmvar rs978458 snpvariantgroup 1 snpcorrespondinggene 3479 snprs 978458 snpcorrespondingspecies 9606 allele high risk meshd003865 combine effect ncbigene3479 ncbigene3479 snptmvar rs978458 snpvariantgroup 1 snpcorrespondinggene 3479 snprs 978458 snpcorrespondingspecies 9606 negative life event associate risk meshd003865 among chinese population
35354635	efficacy gelstix nucleus augmentation device treatment chronic meshd017116 protocol randomize affect control double screen multicentre trial institution discogenic meshd010146 cause meshd010146 26 40 patient meshd017116 consensus treatment chronic meshd017116 lack treatment alternative support limited evidence percutaneous implantation hydrogel nucleus pulposus present promising regenerative intradiscal therapy hydrogel gelstix compose mainly hydrolyze meshc010504 number source hydration produce increase pressure improve ph residue potentially lead disc preservation hypothesise treatment gelstix lead great reduction meshd010146 volume 6 month post treatment compare patient receive affect treatment method analysis twin group randomize affect control double screen multicentre trial ass whether gelstix device superior affect reduce pain int meshd010146 ty patient chronic meshd017116 udy conduct two regional hospital europe 70 two participant randomize 1 1 ratio primary outcome change pain int meshd010146 ty preoperative baseline 6 month postintervention secondary outcome disability quality life patient global effect change scale use pain med meshd010146 ion disc deg meshd055959 assess mean mri change pain int meshd010146 ty disability health related quality life disc peak mean value compare group use linear regression analysis adjust treatment center ethic dissemination ethic approval obtain ethic committee quarter ticino switzerland ce2982 cvcl9l80 medical ethical committee arnhem nijmegen netherlands 2016 2944 patient match participate need signal inform consent form result diffuse external publication match review journal addition external conference introduction trial registration number nct02763956 protocol version 7 1 18 november 2020
